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ABSTRACT 
Tilapiine cichlids are the third largest farmed fish worldwide and are among the 
easiest and most profitable fish to farm.  The most common pathogens affecting farmed 
tilapia are Streptococcus agalactiae and Streptococcus iniae, which together account for 
losses of more than 150 million dollars annually. Fish are at the highest risk for 
developing a Streptococcus infection when they are in high density stock conditions. 
Research indicates that the secondary effects of high stock density such as low dissolved 
oxygen and high ammonia levels are of less significance to infection and mortality than 
the damage that over stocking causes to the mucosal immune system. However, assays 
used to determine the effectiveness of the tilapiine mucosal immune system have proven 
unreliable. The present work has been undertaken to evaluate mucus collection 
procedures and antibacterial assay effectiveness. One “spot-on-lawn” assay, four disk 
diffusion assays, and four micro titer plate assays were chosen based upon common 
levels of use in the literature. The assays were executed; however, each of the disk 
diffusion assays failed to accurately measure antibacterial activity when controlled for the 
antibacterial activity of additives. The microtiter plate assays successfully measured 
limited antibacterial activity at lower growth reduction levels of 10-30%. Additionally, 
these assays were administered on samples which were collected from tilapia in an actual 
aquaponics facility in contrast to the majority of experiments which are conducted on fish 
that have been purposely housed in clean and controlled conditions within research 
facilities. This deviation from standard methods introduced additional variables which 
influence assay outcomes; therefore, future research should address these discrepancies. 
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CHAPTER ONE 
REVIEW OF LITERATURE 
Introduction 
Tilapia is the common name for approximately one hundred species of cichlids 
that can be found among three separate genera. The wide range of the term results from 
the etymology of the word “tilapia” which evolved from a Tswana word that simply 
means “fish.” In modern day food production, the term “tilapia” primarily relates to those 
fish of the genus Oreochromis, which traces its genetic roots back 4,000 years to northern 
African waterways where ancient Egyptians began actively farming cichlids. Recent 
decades have seen the growth of the tilapia industry into a worldwide phenomenon with 
experts ranking tilapia as the second most important farmed fish worldwide, and it has 
been hailed the “most important aquaculture species of the 21st century” (Shelton 2002). 
As our world population continues to rise toward critical levels, agricultural research 
must work to maximize food production with minimal space and less than ideal 
resources.  
In this potential future where the human race exceeds the planet’s carrying 
capacity, tilapia species may become instrumental in feeding a hungry world, as tilapia 
can be raised in small spaces with nominal energy and water input, yet they quickly 
become a high quality protein source loaded with essential fatty acids. In many respects, 
tilapia represents the perfect species for the constraints of future production. Oreochromis 
is tolerant of salinity levels from freshwater to brackish (Kamal 2005), as well as, being 
tolerant of extended periods of low dissolved oxygen levels due to their ability to down 
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regulate cardiac function (Lague 2012). Tilapia can thrive with stocking rates as high as 
50-60 large fish per single 4 m3 tank (Yi 1996) while being prolific and having a growth 
rate of 2-3% of body weight per day (USDA 1991).  Additionally, tilapia offer these 
benefits while consistently being low trophic level feeders (Waite 2014).  
Although tilapia farming is on the rise world-wide, the greatest current threat to 
commercial tilapia production is Streptococcus infection. Both Streptococcus agalactiae 
and Streptococcus iniae are opportunistic diseases that arise when tilapia are stocked at 
high densities, such as is common in commercial facilities. These infections are often 
fatal for tilapia within three to five days of exposure. To prevent major profit loss, 
aquaculturists often resort to extensive use of antibiotics, which poses the potential risk of 
providing an environment where antimicrobial resistance genes could pool. The World 
Health Organization has been working since 2006 to quantify this risk; however, based 
upon emerging scientific consensus, WHO guidelines currently recommend minimizing 
the use of antibiotics that are considered “critically important to human medicine” (WHO 
2011). Many of these antibiotics, including penicillins, sulphonimides, and tetracyclines, 
have seen widespread used in worldwide aquaculture (Sapakota 2008). In an effort to 
minimize the use of antibiotics in aquaculture, research is underway by investigators who 
seek to find novel approaches that enhance the tilapia’s immune system, specifically the 
quality, quantity, and composition of the fish’s external mucosal immune system (Gomez 
2013). 
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The Teleost Immune System: an Overview 
Teleost (finned) fish were the first group to evolve at the beginning of the 
adaptive radiation of vertebrates. Therefore, jawed fishes emerged at the crossroads 
between animals with simple innate immunity and animals that have both innate and 
highly developed adaptive immune systems. Teleost fish have both innate and adaptive 
systems; however, their adaptive immune system is significantly less effective than the 
mammalian system while their innate pathways offer more robust responses than those of 
their mammalian counterparts. More specifically, antibody affinity is lower in fish than 
mammals, memory response is weaker, and affinity maturation is absent due to a lack of 
lymph nodes and germinal centers (Tort 2003). However, recent research has pointed 
toward the presence of melano-macrophage centers in the stroma of the spleen which 
function as proto-germinal centers; however, only preliminary data currently exists 
(Magor 2015). This inhibition of adaptive immunity also hinders the ability of 
immunizations to prevent disease in fish.  
In general terms, the teleost immune system protects the fish with non-specific 
barriers like the scales and mucosa which act as both a physical barrier sequestering 
invading microbes until sloughing and a chemical barrier which inactivates potential 
infectious agents through the actions of antimicrobial peptides, lysozymes, and 
interferons. The telost immune system also protects the fish in specific ways using 
antibody production, though the memory response is slower, weaker, and of shorter 
duration than that of mammals (Iwama 1996). 
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Tilapiine Immune Anatomical Structures  
The tilapia’s lymphoid organs include the kidney, thymus, and spleen. In tilapia, 
as with other jawed fishes, the kidney runs the length of the animal’s medial axis, and the 
head of the kidney is responsible for hemopoietic functions, in addition to being the site 
of antigen processing and phagocytosis (Zapata 1996). Early B-cell development occurs 
in the anterior portion of the head kidney which allows naïve B cells to be transferred to 
the spleen and posterior kidney through the bloodstream. The tilapiine thymus produces 
functional T lymphocytes which drive the adaptive immune response (Bowden 2005). 
The spleen is primarily involved in macrophage phagocytosis of antigens and detaining 
antigens for adequate periods of time to allow for the work of immunological memory 
(Uribe 2011). Tilapia leukocytes can be found in most organs and systems of its body; 
however, they are primarily found in the mucosal associated lymphoid tissue which can 
be found in the gut, skin, and gills (Beck 2015). (See section 1.5 for more information on 
the mucosal immune system). 
 
Figure 1.1: Anatomical Structures of the Teleost Immune System (Evolution 2016). 
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Tilapiine Immune Cellular Components 
Tilapia exhibit versions of the immune cells one expects to find in vertebrates 
including: B and T lymphocytes, natural killer cells, monocytes, macrophages, 
neutrophils, eosinophils, mast cells, and thrombocytes (Whyte 2007). B and T cells both 
undergo the somatic VDJC rearrangement necessary to form antigen specific receptors, 
leading to an extensive repertoire of unique cells. In all teleost fish, there are four known 
immunoglobulins produced: IgM, IgZ, IgT, and IgD; however, isotype switching is not 
possible in tilapia (Beck 2015).  
 
Figure 1.2: Diagram of Immunoglobulin Production in Teleosts (Flajnik 2005). 
IgZ is only produced in the head kidney (1). IgM is produced in the head kidney (2), but 
IgM producing cells may then migrate to the spleen (3). Upon stimulation by antigen, 
IgM producing cells may return to the head kidney (4). 
 
6 
 
As with mammals, B cells function in antigen presenting and antibody 
production; however, teleost B cells also have additional phagocytic abilities (Salinas 
2011).  Genetic studies of T cells in teleosts have shown that all of the genetic 
components necessary for mammalian-level T cell function are present; however, much 
of this research is often still in question. For example, CD4 is expressed on T cells in 
teleosts, but a lack of specific blocking/labeling-antibodies has led to a lack of 
information on the exact nature of this receptor’s function (Beck 2015). Two natural 
killer cell homologs can be found in tilapia: nonspecific cytotoxic cells (NCCs) and NK-
like cells. These cells target non-self recognized invaders, particularly protozoans (Evans 
1990). Macrophages were long thought to work similarly to those in mammals with 
certain macrophages being activated by Th1 while others by Th2; however, more recent 
work indicates that teleost macrophages (and monocytes) can also be activated 
alternatively. Teleost macrophages are divided into four phenotypes: innately activated 
macrophages which are activated by antigen, classically activated macrophages which are 
activated by antigen plus IFNγ, alternatively activated macrophages which are activated 
in the presence of interleukin 4 and interleukin 13, and macrophages which are activated 
in the presence of interleukin 10. Those alternatively activated in the presence of IL 4 and 
IL 13 function in wound healing while those alternatively activated by IL 10 service a 
regulatory function by reducing inflammatory responses (Forlenza 2011). Current 
knowledge indicates that neutrophils, eosinophils, mast cells, and thrombocytes have 
identical functions to those known in vertebrates (Beck 2015). 
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Tilapiine Mucosal Immune System 
The mucus producing tissues of the gills, intestines, and skin comprise the 
mucosal immune system. The specific structures and functions of each of these regions 
vary slightly; however, they share the same basic structure. This structure includes the 
epithelial surface with mucus secreting goblet cells, supportive stromal tissues, vascular 
supply, musculature, and immunologically reactive cells (Beck 2015). The tilapiine 
mucosa is structurally similar to its mammalian counterparts. However, the tilapia’s 
aquatic environment allows for constant contact between the animal and the surrounding 
microflora. This increased contact results in a mucosal immune system that is much more 
dependent on the conditions of the environment to be functional; therefore, it is sensitive 
the effects of pH, temperature, dissolved oxygen, as well as, other factors (Beck 2015).   
 The mucosa of the integument makes up the largest portion of the mucosa-
associated immune system in tilapia. The integument contains a multitude of mucus 
producing goblet cells which are interspersed among simple squamous cells which have 
underlying dermal, sub dermal, and muscle layers. Goblet cells produce highly branched, 
viscous glycoproteins called mucins. These goblet cells are continually being sloughed 
off along with the squamous cells, but new cells are in continuous production in the lower 
tissues of the integument (Beck 2015). The epidermal mucus layer produced by these 
goblet cells contains lysozymes, antimicrobial peptides, proteases, peroxidases, and 
lectins (Salinas 2011). Additionally, resident dendritic cells are present to process 
antigen. B cells are also present, along with antibodies in the form of IgM and IgT. These 
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immunoglobulins are assisted across mucosal barriers via the polymeric immunoglobulin 
receptor (Gomez 2013). Mast cells and eosinophils have been found in the dermal layer 
but not in the mucosa itself. T cells are also present, but the exact nature of T cell action 
in the fish mucosa and integument is still in question (Salinas 2015). The external mucosa 
is also home to commensal bacteria which have unique adhesion properties that allow 
them to claim regions of the tilapiine mucosa which they defend against all invaders, 
pathogenic and otherwise (Grześkowia 2011).  
The gills are a mucosal tissue with the primary role of gas exchange; however, the 
surface mucus layer also functions in immunity. The surface of the gill features both 
primary lamellae which are responsible for increasing surface area and allowing for 
additional exchange. Secondary lamellae then branch from the primary, further extending 
surface area. Among these secondary lamellae are goblet cells, such as those found in the 
integument previously discussed. While these structures add to the oxygenating 
capabilities of the gills, they could potentially hinder the immune response because they 
are so dense that the ability of immunoglobulin and other cell types to have the space 
necessary for movement and interactions with pathogens. The gill mucosa overcomes this 
barrier with specialized cuffs which surround the vasculature of each individual filament. 
These cuffs are able to secrete localized IgM in response to the presence of antigen, thus 
removing the need for the antibodies to circulate over larger distances on the gill 
(Davidson 1997).   
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The intestinal mucosa of the tilapia is similar in structure and function to the 
mammalian gut. There is an initial aqueous layer, followed by a thick mucosal layer, 
which covers a third layer of columnar epithelial cells: the functional enterocytes 
responsible for nutrient absorption. As with the integumentary and gill systems, goblet 
cells are interspersed between enterocytes, though the frequency of goblet cells decreases 
near the posterior end of the intestines (Beck 2015). Though the mucosa of the tilapiine 
gut functions largely in the same manner as that of the gills and skin, a primary difference 
lies in a significant reduction in the number of resident dendritic cells. This lack of 
dendritic cells is likely due to the increased need for commensal bacteria in the gut that 
are necessary for proper digestion (Gomez 2013).  
Relevant Tilapiine Pathogens 
Streptococcus agalactiae/ Streptococcus iniae 
S. agalactiae represents the only Group B streptococcus according to the 
Lancefield classification system. S. agalactiae forms chains of Gram positive cocci. It is 
a facultative anaerobic bacterium that exhibits beta hemolysis and produces alkaline 
phosphatase; it also produces acid in the presence of ribose and trehalose sugars (Whiley 
2009; Holt 1994). S. agalactiae is a largely harmless commensal gut and reproductive 
tract bacteria in humans; however, it can be an opportunistic infection in neonates and 
adults with compromised immune systems (Edwards 2011). S. agalactiae is also one of 
the primary causes of mastitis in dairy cattle (Stableforth 1950).  
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In tilapia, S. agalactiae infection is primarily observed in farmed fish. The initial 
symptom of the infection is an isolated lesion found near the lip or tail line of the fish. 
These lesions are small enough to be easily missed by casual inspection of an aquaculture 
crop. Untreated infection leads to septicemia, hemorrhaging, swirling behavior, bent 
bodies, anorexia, lethargy, and death, often within seven days of the emergence of visible 
symptoms. Cases have been confirmed of initial asymptomatic infection that also proved 
fatal (Pretto-Giordano 2010).  
Much like S. agalactiae, S. iniae is a Gram-positive coccus and facultative 
anaerobe which exhibits beta hemolysis; however, it cannot be grouped according to the 
Lancefield system because it does not express any of the antigens necessary for 
categorization. Genomic analysis indicates that it is closely related to S. agalactiae, and 
the pathology of the two streptococci is nearly identical, requiring bacterial isolation to 
identify (Russo 2006). S. iniae is a human pathogen, causing cellulitis in a small number 
of confirmed cases worldwide, two of which involved injuries at a fish processing facility 
(Lau 2003). Both species of Streptococcus thrive on blood agar plates and in tryptic soy 
broth when incubated at 37°C.  
11 
 
 
Figure 1.3: Tail line ulceration on tilapia infected with Streptococcus agalactiae 
(Vetbook 2015). 
 
Figure 1.4: Streptococcus agalactiae colonies on sheep’s blood agar. 
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Figure 1.5 Streptococcus iniae colonies on sheep’s blood agar. 
 Aeromonas salmonicida 
A. salmonicida was included in this study to comparatively observe the 
antibacterial activity of tilapia mucus against a Gram-negative organism. Although tilapia 
are susceptible to this disease, A. salmonicida does not pose the threat to tilapia 
aquaculture production that S. iniae and S. agalactiae do (Austin 2016). A. salmonicida is 
a rod shaped non-motile bacterium that is a facultative anaerobe; it grows well on blood 
agar plates and in tryptic soy broth at ambient temperatures of approximately 25°C, 
though the colonies diffuse a brown pigment into blood agar. A. salmonicida is not a 
known human pathogen (Shaw 1992).   
A. salmonicida is found primarily in aquaculture sites with poor water quality 
where it causes a disease known as funrunculosis or “tail rot.” Additional external signs 
of infection include swelling around the vents, ulcers, and liquefied feces. Internally, fish 
with A. salmonicida suffer from hemorrhaging which can be acute or chronic. Once the 
fish exhibits extreme lethargy or swirling behavior, death is imminent (Noga 2010).    
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Figure 1.6: Aeromonas salmonicida colonies on sheep’s blood agar. 
Yersinia ruckeri 
Y. ruckeri was also included in this study to provide comparative information 
about additional fish diseases that tilapia reportedly have more resistance to than S. 
agalactiae and S. iniae. While Y. ruckeri causes significant loses to other species in the 
aquaculture industry, tilapia are not highly susceptible. Y. ruckeri is a Gram-negative rod-
shaped enterobacterium that is a facultative anaerobe (Tobback 2007).  
Y. ruckeri causes enteric red mouth disease in many species of fish, as the redness 
is the result of hemorrhaging of the gums and the inside of the mouth. Other symptoms 
include inflammation of the intestines which leads to anorexia, darkening of the skin, 
enlargement of the spleen, and protrusion of the eye. Untreated, Y. ruckeri results in 
massive internal hemorrhaging and death (Noga 2010).    
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Figure 1.7: Yersinia ruckeri colonies on sheep’s blood agar. 
Importance of Mucosa in Preventing Streptococcus Infection 
 An evaluation of multiple studies indicates that the mucosal immune system plays 
an important role in preventing Streptococcus infection. In 2000, Shoemaker, et al. 
produced evidence that stocking densities influence infection rate more than the overall 
concentration of bacteria. This result is potentially a byproduct of the conditions that 
overstocking creates i.e. low dissolved oxygen and/or high ammonia which affect the 
overall health of the tilapia, leading to immunocompromised stock. However, this result 
is also potentially the result of physical damage that overstocking causes to the fish 
external mucosa, or a combination of multiple factors. In an effort to determine the 
underlying issues with overstocking, a study was designed in which tilapia were 
challenged with Streptococcus agalactiae via injection while being held in tanks with 
both normal dissolved oxygen and low dissolved oxygen. In essence, this study mimicked 
the conditions of high density stocking without the physical damage to the mucosa. The 
results of this particular study indicate that low oxygen does affect mortality rates but not 
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infection rates (Evans 2003). In contrast, a separate research team conducted a similar 
experiment by mimicking the conditions of high stocking density (low dissolved oxygen 
and high ammonia concentration). In this study, the fish were challenged with 
Streptococcus agalactiae via immersion. Results showed no difference in infection or 
mortality rates between fish housed in poor conditions (dissolved oxygen <1.0 mg/L and 
ammonia >10 mg/L) and those housed in normal conditions (dissolved oxygen >5 mg/L 
and ammonia <2 mg/L). Therefore, fish that were challenged in such a way that the 
mucosa was bypassed (injection) were further affected by the conditions of the tank, and 
fish that were challenged in such a way that the mucosa was not bypassed (immersion), 
did not have higher infection rates in poor conditions (Bowser 1998). The combination of 
this research belies the importance of the epidermal mucosa in preventing Streptococcus 
infection, as well as, the importance that stocking density plays in infection rates, though 
further research is necessary. Therefore, the purpose of the present study is to determine 
the ideal methodology for quantifying the antibiotic activity of tilapia external mucus in 
tilapia being housed in the practical conditions of aquaculture facilities so that this 
activity can be evaluated in terms of resistance to Streptococcus disease.   
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CHAPTER TWO 
METHODS AND MATERIALS 
Institutional Approval 
The following research methods gained approval from the Clemson University 
Office of Research Compliance’s Institutional Biosafety Committee. This approval was 
granted for the period of June 7, 2016 until June 6, 2017 under the protocol number 
#IBC2016-21.  
Collection Methods 
Mucus was collected from tilapia at two locations: the Clemson University 
Aquaponics Facility and a professional aquaponics farm in Anderson, South Carolina. 
Three different mucus collection methods were evaluated. For each method, the tilapia 
specimen was rinsed with sterile distilled water and placed on a large tempered glass 
surface sterilized with 70% ethanol. Glass microscope slides which had been autoclaved 
(15 min gravity cycle), a spatula which had been autoclaved (20 min gravity cycle), and a 
Corning Incorporated 3011 sterile cell scraper were each used to scrape mucus from the 
dorsolateral surfaces of the fish, avoiding the urogenital area. Using each of these 
methods, mucus was scraped from fish on to the large glass surface. Sterile microscope 
slides were then used to move the mucus from the glass surface into the 50 mL conical 
tube.  
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Quantification of Protein 
 For the purposes of this study, the protein was quantified via electrophoresis and 
spectrophotometry. Prior to the electrophoresis protein quantification, a chloroform 
methanol precipitation was undertaken to concentrate the protein following the method 
set forth by Wessel and Flugge in their textbook Analysis of Biochemistry (Wessel 1984). 
Four hundred µL of methanol was added to 100 µL of crude mucus sample agitated on a 
Vortex Genie 2 for 5 min. An additional 100 µL  of chloroform was added to the 
solution, and it was again agitated for 5 min. Three hundred µL of distilled water were 
added, followed by an additional 5 min of agitation. The solution was then centrifuged at 
21,913 x g for 1 min. The top aqueous layer was removed, 400 µL of methanol were 
added, and the solution was agitated for 5 min and centrifuged at 21,913 x g for 2 min. 
The remaining methanol was removed via micropipette as not to disturb the pellet.  The 
sample was then dried using a speedvac. Finally, 20 µL of loading buffer were added, 
and the sample was prepared for electrophoresis using a BioRad Mini-protein TGX 
Precast trisglycine gel. Upon completion, the gel was compared to the blue standard from 
BioRad Precision Protein Plus.  
 In order to quantify the protein in the mucus samples, a Eppendorf 
Biospectrophotometer 2 was used to compare the sample absorbance at 280 nm to a 
standard curve. Crude samples of 5 mL were diluted with an additional 5 mL of 
phosphate buffered saline prior to quantification. The samples were then centrifuged at 
21,913 x g for 15 min using a Pall Life Sciences Nanosep Centrifugal Device for 
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concentrating and desalting. Thereafter, the filtrate and the sample were measured via 
A280 for protein analysis.  
Standardizing Bacterial Cultures 
 Cultures of Streptococcus agalactiae (ATCC 13813), Streptococcus iniae (ATCC 
29177), Aeromonas salmonicida (ATCC 33658), and Yersinia ruckeri (ATCC 29473) 
were started from Microbiologics Kwik Stik preparations and grown in tryptic soy broth 
(TSB) in 50 mL sterile, conical tubes. The Streptococcus species were incubated at 37°C 
for 24 hours while the A. salmonicida and Y. ruckeri cultures were grown at ambient 
room temperature. Cultures were plated to ensure the presence of a monoculture which 
was consistent with known growth patterns including color, shape, and hemolysis for 
each species of bacteria. Under sterile conditions, the Thermo Scientific Genesys 20 
spectrophotometer was set to absorbance 600 nm, and a cuvette of sterile TSB was read 
as a blank. Ratios of TSB to culture were used until an absorbance of 0.5 to 0.6 was 
achieved for initial experiments and the concentration was reduced to 0.2 for later 
experiments (see discussion). These ratios were then used to create 10 mL of culture in a 
sterile conical tube.  
Contamination Prevention 
 In order to evaluate the amount of bacterial contamination of the mucus, samples 
were streaked four ways onto plates with a variety of media including the following: 
• Sheep Blood Agar 
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• Tryptic Soy Agar 
• MacConkey Agar 
• Eosin Methylene Blue Agar  
• Mannitol Salt Agar 
• Phenylethyl Alcohol Agar 
• CHROMagar™ Orientation Agar  
The plates were then evaluated for colony growth by a visual inspection of size, 
hemolysis, color, and shape. Once it was determined that contamination had occurred, 
methods were evaluated to eliminate cellular growth without the degradation of proteins. 
One portion of sample was freeze dried in the Lyo-Centre lyophilizer, resuspended, and 
plated on a sterile plate with sheep blood agar. Another portion of sample in PBS was 
thinly spread across a 100 mm x 15 mm sterile plate under a Thermo Scientific 1300 
Series A2 hood while under direct ultraviolet light for 20 min. The sample was then 
collected into a sterile conical tube and plated on sterile sheep blood agar to assess 
bacterial growth. Plates were examined at 12 and 24 hr.   
Antibacterial Assays 
Spot-on-Lawn Assay 
Twenty-four hour cultures of Streptococcus agalactiae, Streptococcus iniae, 
Aeromonas salmonicida, and Yersinia ruckeri were standardized and streaked onto sheep 
blood agar plates. Five mL of mucus was collected from two fish into sterile tubes one of 
which contained 5 mL of sterile distilled water, while the other contained 5 mL of a 3% 
20 
 
acetic acid solution. This mixture was taken immediately into the lab where it was 
agitated for 5 min. Thirty µL of each sample was spotted onto the blood agar plate in 
each of four quadrants. The plates were then incubated at 20°C, and the inhibition zones 
were measured at 24 hrs. Sterile distilled water and bleach were also spotted as positive 
and negative controls, respectively.  
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Disk Diffusion Assay with Lyophilization 
Five mL samples of mucus were collected into sterile conical tubes which 
contained 5 mL of sterile distilled water. The mixture was agitated for 5 min and stored 
overnight at -80°C. The sample was then lyophilized for 24 hrs. The dried sample was 
then divided into two parts by weight. One part was dissolved in 3% acetic acid solution 
and the remaining portion was dissolved in sterile, triple distilled water. Acetic acid was 
included to enhance the solubility of the proteins (Kumari et al. 2011, Subramanian et al. 
2008, Nigam et al. 2015, Wei et al. 2010). Each aliquot was agitated for 5 min and 
centrifuged at 10,000 x g at 4°C for 15 min. Thirty µL of each sample was impregnated 
onto sterile 6 mm disks and placed onto the surface of the impregnated agar with sterile 
forceps. Thirty µL of distilled water, bleach, and 3% acetic acid were added to sterile 
disks. Bleach served as a positive control while distilled water is a negative control, and 
acetic acid is a component control. The Streptococcus plates were then incubated at 37°C, 
while the Aeromonas salmonicida and Yersinia ruckeri plates were incubated at 20°C. 
Zone of inhibition measurements were taken at 24 hrs.    
Disk Diffusion Assay with UV Sterilization of Liquid Sample 
Five mL samples of mucus were collected into sterile conical tubes which 
contained either 5 mL of sterile distilled water or 5 mL of 3% acetic acid. The mixture 
was taken straight to the lab where it was agitated for 5 min. While in sterile conditions, 
the samples were poured into sterile petri dishes and placed within 15 cm of direct UV 
light for 20 min. Thirty µL of sample were then pipetted onto 6 mm sterile disks and 
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placed upon the surface of impregnated agar plates. Thirty µL of distilled water, bleach, 
and 3% acetic acid were added to sterile disks. Bleach serves as a positive control while 
distilled water is a negative control, and acetic acid is a component control.   The 
Streptococcus plates were then incubated at 37°C, while the Aeromonas salmonicida and 
Yersinia ruckeri plates were incubated at 20°C. Zone of inhibition measurements were 
taken at 24 hrs.    
Disk Diffusion Assay with UV sterilization of Crude Mucus Samples    
 Under sterile conditions, 6 mm sterile paper disks were used to wipe mucus 
directly from the surface of the fish. These disks were then placed onto sterile petri dishes 
and placed 15 cm from direct UV light for 10 min. These were then turned with sterile 
forceps and left for an additional 10 min. Disks were rewet with 50 µL of phosphate 
buffered saline. These disks were then placed upon the surface of blood agar plates which 
had been impregnated with standardized bacteria. The Streptococcus plates were then 
incubated at 37°C, while the Aeromonas salmonicida and Yersinia ruckeri plates were 
incubated at 20°C. Zone of inhibition measurements were recorded at 24 hrs. 
Disk Diffusion Assay with Chloroform Methanol Precipitation 
Four hundred µL of methanol was added to 100 µL of crude mucus sample and 
vortexed for 5 min. An additional 100 µL of chloroform was added to the solution, and it 
was again vortexed for 5 min. Three hundred µL of distilled water were added, followed 
by an additional 5 min of agitation. The solution was then centrifuged at 21,913 x g for 1 
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min. The top aqueous layer was removed, 400 µL of methanol were added, and the 
solution was vortexed for 5 min and centrifuged at 21,913 x g for 2 min. The remaining 
methanol was removed via micropipette as not to disturb the pellet.  The sample was then 
dried using a speedvac (Wessel 1984). This precipitation was undertaken to concentrate 
the protein, as well as, eliminate any bacterial contamination. The dried pellet was then 
reconstituted with phosphate buffered saline by repeated pipetting, shaking, and 
vortexing at 10 min intervals under sterile conditions. The resuspension was incomplete, 
but spectrophotometer A28 readings showed significant protein had gone into solution. 
The solution was then drawn from the tubes with a micropipetter, accumulated into a 
larger sterile tube, and agitated for 5 min. Thirty µL of the solution was pipetted onto 6 
mm sterile paper disks which had been placed upon the surface of inoculated sheep blood 
agar plates. The Streptococcus plates were then incubated at 37°C, while the Aeromonas 
salmonicida and Yersinia ruckeri plates were incubated at 20°C. Zone of inhibition 
measurements were recorded at 24 hrs.  
Microtiter Broth Dilution Assay with Minimal Sample Processing 
 Five mL of sample was collected, using the cell scraper method described in 
detail in Chapter 2.1, into a sterile conical tube containing an additional 5 mL of 
phosphate buffered saline. The sample was taken immediately to the lab and centrifuged 
for 10 min at 21,913 x g/4°C to remove any epidermal skin cells. The supernatant was 
poured into a sterile petri dish and placed within 15 cm of UV light under sterile 
conditions for 20 min.   
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 A 96-well plate was then prepared with a 1:2 serial dilution of the sample in Rows 
A-D. One hundred fifty µL of 24 hr liquid bacterial cultures (details on culture 
standardization can be found in Section 2.3) were then added to each well. Rows E-F 
were growth control and contained only phosphate buffered saline and standardized 
liquid cultures. The plates were then immediately read on a plate spectrophotometer at 
595 nm following medium shaking. The Streptococcus plates were incubated at 37°C 
while the Aeromonas salmonicida and Yersinia ruckeri plates were incubated at room 
temperature (approximately 20°C). Spectrophotometer readings were taken after 12 and 
24 hrs of incubation. 
Microtiter Broth Dilution Assay with Sodium Acetate  
Five mL of sample was collected, using the cell scraper method described in 
detail in Chapter 2.1, into a sterile conical tube containing 200 µL of sodium acetate 
(NaAc). The sample was taken immediately to the lab and centrifuged at 4°C for 15 min 
at 21,913 x g. The supernatant was the transferred to a larger tube. The pellet was 
resuspended with 300 µL of NaAc, vortexed, and centrifuged for an additional 15 min at 
21,913 x g and 4°C. The second supernatant was merged with the initial and the sample 
was poured into a sterile petri dish where it was held under UV light for 20 min in a 
sterile field.  
 A 96-well plate was then prepared with a 1:2 serial dilution of the sample in rows 
A-D. One hundred fifty µL of 24 hr liquid bacterial cultures were then added to each 
well. Rows E-F were growth control and contained only phosphate buffered saline and 
25 
 
standardized liquid cultures. The plates were then immediately read on a plate 
spectrophotometer at 595 nm with medium shaking. The Streptococcus plates were 
incubated at 37°C while the Aeromonas salmonicida and Yersinia ruckeri plates were 
incubated at room temperature (approximately 20°C). Spectrophotometer readings were 
recorded after 12 and 24 hrs of incubation. 
 Microtiter Broth Dilution Assay to Evaluate Buffer Effectiveness 
A plate assay was run without sample using either NaAc or PBS in 1:2 serial 
dilution along with 150 µL of 24 hr standardized bacterial cultures of Streptococcus 
agalactiae, Streptococcus iniae, Aeromonas salomicida, and Yersinia ruckeri. The plates 
were then immediately read on a Thermo Scientific Multiscan FC plate 
spectrophotometer at 595 nm following medium shaking. The Streptococcus plates were 
incubated at 37°C while the Aeromonas salmonicida and Yersinia ruckeri plates were 
incubated at room temperature (approximately 20°C). Spectrophotometer readings were 
taken after 12 and 24 hr of incubation. 
Microtiter Broth Dilution Assay with PBS and Nanosep Centrifugal Filter 
Five mL of mucus sample was collected using the cell scraper method and added 
to a sterile, conical tube containing 5 mL of PBS. The sample was then centrifuged twice 
at 21,913 x g/4°C, and the supernatants combined. Pall Life Sciences nanosep centrifugal 
device was then used to concentrate and desalt the sample. The nanoseps were prepared 
per instructions by running sterile PBS through the filters with two 10-min 
centrifugations at 21,913 x g/4°C. The sample was then separated into 10 nanosep tubes 
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with a micropipette. The tubes were centrifuged for 10 min at 21,913 x g /4°C, examined, 
and centrifuged for an additional 10 min. The filtrates from each tube were combined. 
One hundred µL of PBS was added to the top portion of each filter (per instructions), 
resuspended, and vortexed. The retentate from each nanosep tube was then combined into 
one sterile tube.  
A 96-well plate was then prepared with a 1:2 serial dilution of the sample in Rows 
A-D. One hundred fifty µL of 24-hr liquid bacterial cultures were then added to each 
well. Rows E-F were growth control and contained only phosphate buffered saline and 
standardized liquid cultures. The plates were then immediately read on a plate 
spectrophotometer at 595 nm following medium shaking. The Streptococcus plates were 
incubated at 37°C while the Aeromonas salmonicida and Yersinia ruckeri plates were 
incubated at room temperature (approximately 20°C). Spectrophotometer readings were 
taken after 12 and 24 hrs of incubation.  
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CHAPTER THREE 
RESULTS AND DISCUSSION 
Sample Collection 
Upon visual inspection and inspection under a light microscope at 4x 
magnification (Figure 3.1), the samples taken via scraping with a microscope slide 
contained a significant amount of skin cells, smaller scales, and other debris which 
required additional centrifugation. The samples taken via cell scraper and spatula 
appeared significantly cleaner. When attempting to collect the mucus, with all three 
methods, it was difficult to get the mucus from the fish into the specimen tube. The most 
efficient method found was to use a cell scraper in conjunction with a sterile microscope 
slide. By scraping the mucus onto the slide at the base of the tail, the mucus could then be 
transferred to the tube by scraping it off the slide. The cell scraper/microscope slide 
method was used for the remainder of this study for convenience as it was pre-sterilized 
while the spatula required a 20 min autoclave gravity cycle. 
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Figure 3.1: Photographs of sample mucus smears stained with Wright’s stain. Figures A, B and C are photos of smears of 
mucus taken via cell scraper. Figures D, E, and F are photos of smears of mucus taken via scraping with a sterile glass 
microscope slide. All photos were taken of the same size field of vision under 4x magnification.   
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Protein Quantification Results 
Analysis of Protein via BioSpectrophotometer 
Figure 3.2 (below) represents the protein quantification via spectrophotometer at 
absorbance 280 for the crude mucus samples, with dilution factors taken into account. 
The three trials of quantification for crude mucus detected the large quantities of protein 
one would expect from unprocessed mucus at 28.598, 27.775 and 28.021 mg/mL. This 
result indicates that the samples, taken from three different tanks of fish at two locations, 
are composed of similar amounts of total protein, though the composition of those 
proteins was not determined.  
Figure 3.3 represents the protein quantification for the samples in the rententate 
following the use of a centrifugation filter which concentrates proteins while Figure 3.4 
represent the protein quantification for the samples in the filtrate following the same 
protein concentration centrifugation. The purpose of this measurement was to determine 
if the concentrating filter was successful in retaining protein, as the literature reports that 
the antibacterial proteins in fish mucus are small peptides (Ebram 1999). Measurements 
taken of the retentate resulted in readings of 8.846, 9.032, and 8.537 mg/mL while those 
taken of the filtrate resulted in readings of 1.172, 0.613, and 1.684 mg/mL. This result 
indicates that the concentrating centrifugation filter had similar effects on each of the 
three samples and that more protein remained in the retentate than the filtrate. However, 
because protein was found in the filtrate, both retentate and filtrate were used in 
antibacterial assays to assess activity. 
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Figure 3.2: Curves representing density of crude protein sample per absorbance 280 for three trials. 
 
 
 
 
 
 
 
 
 
 
31 
 
Figure 3.3: Curves representing density of retentate protein sample per absorbance 280 for three trials. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 9.032 mg/mL 8.846  mg/mL 8.537 mg/mL 
Trial 1 Trial 2 Trial 3 
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Figure 3.4: Curves representing density of filtrate protein sample per absorbance 280 for three trials. 
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Protein Analysis via Electrophoresis 
Electrophoresis (Figure 3.5) was used as verification that the proteins contained 
within the mucus were of the same approximate molecular weights as those that have 
been indicated in the literature. The second column of the gel is the Biorad Precision 
Protein Plus blue standard (seen also in the left) and experimental sample is seen in the 
first and third columns. This comparison indicates that the molecular weights of the 
proteins found in the samples for this experiment (approximately 250, 100, 75, 35, and 25 
kDa for the most visible results) are consistent with those found in other experiments 
such as the 233, 104, 88, 78, 51, 46, 38, 31, and 25 previously reported present in tilapia 
mucus (Wibowbo 2015). 
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Figure 3.5: Ladder for the blue standard used from Biorad Precision Protein Plus (left).  
Electrophoresis results with sample in Columns 1 and 3 and blue standard in Column 2 
(right).  
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Contamination Prevention Results 
Contamination was suspected of the disk diffusion assay based upon the presence 
of colonies which have morphologies that were significantly different than the target 
species. Therefore, samples were plated on seven agar types to verify this conclusion and 
to point toward a possible source of contamination. Based upon the color changes 
indicated in the orientation agar and similarities of potential morphologies selected for by 
each agar, the genera of the contaminants is listed below in Table 3.1. This result 
indicates contamination from either the urogenital area of the tilapia during scraping or 
the presence of bacteria found in the water which was heavily contaminated with fecal 
matter in one sampling location. 
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Table 3.1: Suspected contamination species based upon agar selection  
Agar Type Selects For Suspected 
Contamination  
Sheep Blood Agar General bacterial growth, detects 
hemolytic activity 
Unidentified colonies of 3 
different morphologies 
Tryptic Soy Agar General bacterial growth Unidentified colonies  
MacConkey Agar Gram negative bacilli and enteric 
bacilli, differentiates lactose 
fermentation 
Unidentified colonies of 2 
different morphologies 
Eosin Methylene Blue 
Agar 
Gram negative bacilli, 
particularly E. coli 
E.coli, unidentified 
colonies 
Mannitol Salt Agar Bacteria capable of fermenting 
mannitol and/or surviving in a 
high salt environment  
No colony growth   
Phenylethyl Alcohol 
Agar 
Staphylococcus species  Staphylococcus spp. 
CHROMagar™ 
Orientation Agar 
Urinary and enteric pathogens, 
color change per species  
Enterococcus, E. coli, 
unidentified colonies 
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Once contamination was confirmed, methods were evaluated to reduce or 
eliminate the effects of the additional species of bacteria without degrading proteins. Two 
methods were evaluation, treatment of the diluted sample with ultraviolet radiation and 
chloroform methanol precipitation. Ultraviolet treatment was proposed based upon its 
widespread use in sewage treatment facilities where the presence of suspended solids 
does not diminish UV’s effectiveness when the dosage is sufficiently high for the volume 
for liquid being sterilized (Wolfe 1990). Chloroform methanol precipitation was used 
both to decontaminate the sample and concentrate the protein. Chloroform works as an 
antibacterial agent by disrupting the lipids in the cell membrane (Reigada 2013). 
Following each treatment, samples were streaked onto sheep blood agar plates and left to 
incubate for 24 hrs with visual inspection at 12 and 24 hrs. Though both methods were 
largely successful at eliminating or reducing bacterial contamination (see Tables 3.2 and 
3.3 below), the chloroform methanol precipitation requires a speedvac drying step which 
prevented the proteins from completely resuspending in solution; therefore, further 
experimentation involved decontamination via UV light. 
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Table 3.2: Twelve-hour plate growth following UV and Chloroform treatment of sample 
Treatment Trial 1 Trial 2 Trial 3 Trial 4 Trial 5 
UV    -    -    -    -    - 
Chloroform    -    -    -    -    - 
+indicates growth 
−indicates no visible colony growth  
 
Table 3.3: Twenty-four-hour plate growth following UV and Chloroform treatment of 
sample 
Treatment Trial 1 Trial 2 Trial 3 Trial 4 Trial 5 
UV    -    -    -    -    - 
Chloroform    -    +    -    -    - 
+indicates growth 
−indicates no visible colony growth  
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Spot on Lawn Assay Results  
Disk antibacterial assays are considered qualitative but not quantitative 
(Antibiotic 2017); therefore, the results of these assays will be presented as either 
exhibiting antibacterial activity or not. The initial trials of spot-on-lawn assays were done 
prior to decontamination experimentation during which every spot exhibited significant 
growth of bacterial colonies that did not match the morphology of the target organism; 
therefore, the results have not been included in the following discussion.  
When antibacterial activity was detected (Table 3.4), it appeared to be the result 
of two possible factors: contamination with species which produced substances that 
prevented the growth of other colonies around the disk or the presence of 3% acetic acid. 
The contamination issue was dealt with by modifying the protocol to include antibiotic 
measures that should not degrade the necessary proteins. Acetic acid was initially 
included in the protocol because of its frequent use in other published works (Hellio 
2002, Subashimi 2013, Kumari 2011, Nigam 2015, Wei 2010). The inclusion of acetic 
acid in the protocol is linked to its ability to enhance the solubility of the proteins; 
however, in this assay, the 3% acetic acid control produced zones of inhibition without 
the inclusion of sample. Therefore, the inclusion or concentration of acetic acid in 
antibacterial assays merits further research. 
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Table 3.4: Results of spot-on lawn assay trials 1-12/controls 
Trial S. agalactiae S. iniae A. salmonicida Y. ruckeri 
  1 (aqueous) 
− − −   −* 
  2 (aqueous) 
− ° −   −* 
  3 (aqueous) 
− − − − 
  4 (aqueous) 
− − − − 
  5 (aqueous) 
− − − − 
  6 (aqueous) 
− − − − 
  7 (acidic)   +* +   +* + 
  8 (acidic) + + + + 
  9 (acidic) + ° +   +* 
10 (acidic) 
− + +   +* 
11 (acidic) ° + − + 
12 (acidic) 
− − + + 
Bleach + + + + 
D.I.Water 
− − − − 
*indicates contamination 
+indicates antibacterial activity 
−indicates a lack of antibacterial activity 
°indicates insufficient bacterial growth 
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Disk Diffusion Assay with Lyophilization Results 
 As seen in the spot-on-lawn assays, in the disk diffusion assay with lyophilizaion 
(Tables 3.5, 3.6, 3.7, and 3.8 below) antibacterial activity was only detected when in the 
presence of bleach or acetic acid. Lyophilization was also tested within this protocol 
because it is a commonly used practice in the processing of mucus for antibacterial 
testing; however, it has been theorized that the water within the mucus may have been 
“bound irreversibly to the glycoprotein” (Mucus Symposium 2009). If so, the structure of 
the mucus would be damaged significantly, which may affect its ability to act as an 
antibacterial substance. Therefore, future trials were undertaken without lyophilization to 
potentially determine its effect on the antibacterial properties of the mucus (see below). 
Disk diffusion assays cannot distinguish between bacteriostatic and bactericidal 
activities; however, neither of these conditions were detectable in this assay. There are a 
minimum of three possible explanations for this result: diffusion rate, solubility, or a lack 
of antibacterial activity in tilapia mucus. Further research should be undertaken to alter 
each of these variables to determine if another result is possible.  
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Table 3.5: Results of disk diffusion assay with Lyophilization trials 1-12/controls for 
Streptococcus agalactiae 
Trial   1 (aqueous) 
− Trial   1 (acetic) − 
Trial   2 (aqueous) 
− Trial   2 (acetic) + 
Trial   3 (aqueous) 
− Trial   3 (acetic) + 
Trial   4 (aqueous) 
− Trial   4 (acetic) + 
Trial   5 (aqueous) 
− Trial   5 (acetic) − 
Trial   6 (aqueous) 
− Trial   6 (acetic) + 
Trial   7 (aqueous) 
− Trial   7 (acetic) − 
Trial   8 (aqueous) 
− Trial   8 (acetic) + 
Trial   9 (aqueous) 
− Trial   9 (acetic) + 
Trial 10 (aqueous) 
− Trial 10 (acetic) + 
Trial 11 (aqueous) 
− Trial 11 (acetic) + 
Trial 12 (aqueous)   −* Trial 12 (acetic) + 
Bleach + 3% Acetic + 
D.I.Water 
− D.I. Water − 
*indicates contamination 
+indicates antibacterial activity 
−indicates a lack of antibacterial activity 
°indicates insufficient bacterial growth 
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Table 3.6: Results of disk diffusion assay with Lyophilization trials 1-12/controls for 
Streptococcus iniae 
Trial   1 (aqueous) 
− Trial   1 (acetic) + 
Trial   2 (aqueous) 
− Trial   2 (acetic) + 
Trial   3 (aqueous) 
− Trial   3 (acetic) + 
Trial   4 (aqueous) 
− Trial   4 (acetic) + 
Trial   5 (aqueous) 
− Trial   5 (acetic) + 
Trial   6 (aqueous) 
− Trial   6 (acetic) + 
Trial   7 (aqueous) 
− Trial   7 (acetic) + 
Trial   8 (aqueous) 
− Trial   8 (acetic) + 
Trial   9 (aqueous) 
− Trial   9 (acetic) − 
Trial 10 (aqueous) 
− Trial 10 (acetic) + 
Trial 11(aqueous) 
− Trial 11 (acetic) + 
Trial 12 (aqueous) 
− Trial 12 (acetic) − 
Bleach + 3% Acetic + 
D.I.Water 
− D.I. Water − 
*indicates contamination 
+indicates antibacterial activity 
−indicates a lack of antibacterial activity 
°indicates insufficient bacterial growth 
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Table 3.7: Results of disk diffusion assay with Lyophilization trials 1-12/controls for 
Aeromonas salmonicida 
Trial   1 (aqueous) 
− Trial   1 (acetic) + 
Trial   2 (aqueous)   −* Trial   2 (acetic) + 
Trial   3 (aqueous) 
− Trial   3 (acetic) − 
Trial   4 (aqueous) 
− Trial   4 (acetic) + 
Trial   5 (aqueous)   −* Trial   5 (acetic)   +* 
Trial   6 (aqueous) 
− Trial   6 (acetic) + 
Trial   7 (aqueous) 
− Trial   7 (acetic) + 
Trial   8 (aqueous) 
− Trial   8 (acetic) − 
Trial   9 (aqueous) 
− Trial   9 (acetic) − 
Trial 10 (aqueous) 
− Trial 10 (acetic) + 
Trial 11(aqueous) 
− Trial 11 (acetic) + 
Trial 12 (aqueous) 
− Trial 12 (acetic)   +* 
Bleach + 3% Acetic + 
D.I.Water 
− D.I. Water − 
*indicates contamination 
+indicates antibacterial activity 
−indicates a lack of antibacterial activity 
°indicates insufficient bacterial growth 
 
  
45 
 
Table 3.8: Results of disk diffusion assay with Lyophilization trials 1-12/controls for 
Yersinia ruckeri 
Trial   1 (aqueous) 
− Trial   1 (acetic) − 
Trial   2 (aqueous) 
− Trial   2 (acetic) − 
Trial   3 (aqueous) 
− Trial   3 (acetic) + 
Trial   4 (aqueous) 
− Trial   4 (acetic) + 
Trial   5 (aqueous) 
− Trial   5 (acetic) + 
Trial   6 (aqueous) 
− Trial   6 (acetic) + 
Trial   7 (aqueous) 
− Trial   7 (acetic) + 
Trial   8 (aqueous) 
− Trial   8 (acetic) + 
Trial   9 (aqueous) 
− Trial   9 (acetic) + 
Trial 10 (aqueous) 
− Trial 10 (acetic) + 
Trial 11(aqueous) 
− Trial 11 (acetic) + 
Trial 12 (aqueous) 
− Trial 12 (acetic) + 
Bleach + 3% Acetic + 
D.I.Water 
− D.I. Water − 
*indicates contamination 
+indicates antibacterial activity 
−indicates a lack of antibacterial activity 
°indicates insufficient bacterial growth 
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Disk Diffusion Assay with UV Sterilization of Liquid Sample Results  
 
In further attempts to evaluate the disk diffusion assay, a second trial was 
undertaken which removed the lyophilization step (see Tables 3.9, 3.10, 3.11, and 3.12) 
As with the spot-on-lawn assay and the lyophilization disk assay, antibacterial activity 
was only detected in those samples which had been added to the 3% acetic acid solution, 
yet the control for acetic acid without sample was again positive. Therefore, it could not 
be determined if the lyophilizing had an effect on the antibacterial properties of the 
mucus samples. 
 
  
47 
 
Table 3.9: Results of disk diffusion assay with UV sterilization for Streptococcus 
agalactiae 
Trial   1 (aqueous) 
− Trial   1 (acetic) − 
Trial   2 (aqueous) 
− Trial   2 (acetic) + 
Trial   3 (aqueous) 
− Trial   3 (acetic) − 
Trial   4 (aqueous) 
− Trial   4 (acetic) + 
Trial   5 (aqueous) 
− Trial   5 (acetic) + 
Trial   6 (aqueous) 
− Trial   6 (acetic) + 
Trial   7 (aqueous) 
− Trial   7 (acetic) + 
Trial   8 (aqueous) 
− Trial   8 (acetic) − 
Trial   9 (aqueous) 
− Trial   9 (acetic) − 
Trial 10 (aqueous) 
− Trial 10 (acetic) + 
Trial 11(aqueous) 
− Trial 11 (acetic) + 
Trial 12 (aqueous) 
− Trial 12 (acetic) + 
Bleach 
− 3% Acetic + 
D.I.Water 
− D.I. Water − 
*indicates contamination 
+indicates antibacterial activity 
−indicates a lack of antibacterial activity 
°indicates insufficient bacterial growth 
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Table 3.10: Results of disk diffusion assay with UV sterilization for Streptococcus iniae 
Trial   1 (aqueous) 
− Trial   1 (acetic) + 
Trial   2 (aqueous) 
− Trial   2 (acetic) + 
Trial   3 (aqueous) 
− Trial   3 (acetic) − 
Trial   4 (aqueous) 
− Trial   4 (acetic) − 
Trial   5 (aqueous) 
− Trial   5 (acetic) + 
Trial   6 (aqueous) 
− Trial   6 (acetic) + 
Trial   7 (aqueous) 
− Trial   7 (acetic) + 
Trial   8 (aqueous)   +* Trial   8 (acetic) 
− 
Trial   9 (aqueous) 
− Trial   9 (acetic) + 
Trial 10 (aqueous) 
− Trial 10 (acetic) + 
Trial 11(aqueous) 
− Trial 11 (acetic) + 
Trial 12 (aqueous) 
− Trial 12 (acetic) − 
Bleach + 3% Acetic + 
D.I.Water 
− D.I. Water − 
*indicates contamination 
+indicates antibacterial activity 
−indicates a lack of antibacterial activity 
°indicates insufficient bacterial growth 
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Table 3.11: Results of disk diffusion assay with UV sterilization for Aeromonas 
salmonicida 
Trial   1 (aqueous) 
− Trial   1 (acetic) + 
Trial   2 (aqueous) 
− Trial   2 (acetic) + 
Trial   3 (aqueous) 
− Trial   3 (acetic)   +* 
Trial   4 (aqueous) 
− Trial   4 (acetic) + 
Trial   5 (aqueous) 
− Trial   5 (acetic) + 
Trial   6 (aqueous) 
− Trial   6 (acetic) − 
Trial   7 (aqueous)   −* Trial   7 (acetic) + 
Trial   8 (aqueous) 
− Trial   8 (acetic) − 
Trial   9 (aqueous) 
− Trial  9 (acetic) + 
Trial 10 (aqueous) 
− Trial 10 (acetic) − 
Trial 11(aqueous)   −* Trial 11 (acetic) − 
Trial 12 (aqueous) 
− Trial 12 (acetic) + 
Bleach + 3% Acetic + 
D.I.Water 
− D.I. Water − 
*indicates contamination 
+indicates antibacterial activity 
−indicates a lack of antibacterial activity 
°indicates insufficient bacterial growth 
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Table 3.12: Results of disk diffusion assay with UV sterilization for Yersinia ruckeri 
Trial   1 (aqueous)   −* Trial   1 (acetic)   +* 
Trial   2 (aqueous) 
− Trial   2 (acetic) + 
Trial   3 (aqueous) 
− Trial   3 (acetic) − 
Trial   4 (aqueous)   −* Trial   4 (acetic)   +* 
Trial   5 (aqueous)   −* Trial   5 (acetic)   +* 
Trial   6 (aqueous) 
− Trial   6 (acetic) + 
Trial   7 (aqueous) 
− Trial   7 (acetic) + 
Trial   8 (aqueous) 
− Trial   8 (acetic) − 
Trial   9 (aqueous) 
− Trial   9 (acetic) − 
Trial 10 (aqueous) 
− Trial 10 (acetic) + 
Trial 11(aqueous) 
− Trial 11 (acetic) + 
Trial 12 (aqueous) 
− Trial 12 (acetic) − 
Bleach + 3% Acetic + 
D.I.Water 
− D.I. Water − 
*indicates contamination 
+indicates antibacterial activity 
−indicates a lack of antibacterial activity 
°indicates insufficient bacterial growth 
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Disk Diffusion Assay with UV sterilization of Crude Mucus Results  
 Given the results of the previous assays, questions arose about a possible lack of 
uniformity of the density of the proteins within the mucus. In other words, are the mucus 
proteins evenly spread throughout the solution, and if not, could this account for the lack 
of antibacterial activity? Therefore, an additional assay was devised which evenly spread 
mucus across the disk directly from the surface (results in Table 3.13 below). The disks 
were held with sterile forceps and used to wipe the mucus directly from the surface of the 
fish. The disks were then held under UV and resuspended with 50 µL of sterile distilled 
water. As with previously discussed disk diffusion assays, no antibacterial activity was 
measured except in cases of contamination. These zones of inhibition were likely caused 
by the invading bacteria. It is unclear if the lack of antibacterial activity is the result of a 
lack of solubility of the sample which may have adhered too well to the disk. This result 
led to further experimentation to test chloroform as an antimicrobial agent and to ensure 
that the UV light was not degrading any of the necessary peptides and proteins found in 
the sample. 
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Table 3.13: Results of disk diffusion assay with UV sterilization of crude mucus for all 
diseases 
 S. agalactiae S. iniae A. salmonicia Y. ruckeri 
Trial   1 
− − −   +* 
Trial   2 
− − − − 
Trial   3 
− − − − 
Trial   4 
− − − − 
Trial   5 
− − − − 
Trial   6 
− − − − 
Trial   7 
− − − − 
Trial   8   +* 
− − − 
Trial   9 
− − − − 
Trial 10 
− − − − 
Trial 11 
− − − − 
Trial 12 
−   −* − − 
Bleach + + + + 
D.I.Water 
− − − − 
PBS 
− − − − 
*indicates contamination 
+indicates antibacterial activity 
−indicates a lack of antibacterial activity 
°indicates insufficient bacterial growth 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
53 
 
Disk Diffusion Assay with Chloroform Methanol Precipitation Results  
 A chloroform methanol precipitation assay was carried out to evaluate chloroform 
as a possible method of removing contaminating bacteria. The chloroform would then be 
evaporated during the speedvac process and would not affect the antibacterial activity of 
the assay itself. The additional benefit of this precipitation is protein concentration which 
should amplify the effects of the antimicrobial proteins in the same. Unfortunately, the 
protein pellet that remained after speedvac drying did not go back into solution well even 
upon repeated agitation via vortex and micropipetting. The results of the assay can be 
seen in Table 3.14 below; however, it is unlikely that enough of the protein entered into 
solution for any antibacterial results to occur.  
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Table 3.14: Results of disk diffusion assay with chloroform methanol for all diseases 
 S. agalactiae S. iniae A. salmonicida Y. ruckeri 
Trial   1 
−   +* − − 
Trial   2 
− − − − 
Trial   3 
− − − − 
Trial   4 
− − − − 
Trial   5 
− − − − 
Trial   6 
− − − − 
Trial   7 
− − − − 
Trial   8 
− − − 
− 
Trial   9 
− − − − 
Trial 10 
− − − − 
Trial 11 
− − − − 
Trial 12 
− − − − 
Bleach + + + + 
D.I.Water 
− − − − 
PBS 
− − − − 
*indicates contamination 
+indicates antibacterial activity 
−indicates a lack of antibacterial activity 
°indicates insufficient bacterial growth 
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Microtiter Plate Assay with Minimal Sample Processing Results 
 The results of the spot-on-lawn and disk diffusion assays indicated a lack of 
sensitivity in measuring the antibacterial activity in fish mucus, which the literature 
overwhelmingly supports. Therefore, experiments using a microtiter method of reading 
growth via spectrophotometer were undertaken as a more sensitive method of 
determining antimicrobial activity. In this initial run, the sample was simply centrifuged 
to remove epidermal cells, placed under UV, and diluted in a small amount of phosphate 
buffered saline prior to the plate assay.  
For the purposes of this assay, antibacterial activity was calculated by taking a 
percentage of the growth control mean and subtracting it from the change in turbidity 
over time. The resulting cells that were less than zero were considered to indicate 
antibacterial activity, assessed as a total of antibacterial units based upon the dilution 
factor of each well. An antibacterial unit is defined as the reciprocal of the dilution factor 
for each well that inhibited growth by 50% (Faye et al. 2002, Singh et al. 2012, Wang 
2010). For the purposes of this study, growth inhibition percentages lower than 50% were 
also calculated. The measurements are then averaged from three trials and displayed in 
Tables 3.15 and 3.16 below. Percentages are calculated based on percentage of growth 
control mean and represent a reduction in growth by that factor. This assay was 
successful in detecting significant antibacterial activity of the sample for all diseases:  S. 
agalactiae, S.iniae, A. salmonicida, and Y. ruckeri (Table 3.15 and 3.16 below). The raw 
data for this assay can be found in Appendix A.  
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Table 3.15 Antibacterial activity for minimal processing assay at 12 hours for all diseases 
calculated in antibacterial units. 
Antibacterial Activity at 12 hours (in Antibacterial Units/ml) 
 S. agalactiae S. iniae A. salmonicida Y. ruckeri 
10% growth reduction 44.33 2731.67 2.33 1279.67 
20% growth reduction 40.00 2696.67 1.67 1311.67 
30% growth reduction 29.00 0.00 1.00 586.00 
40% growth reduction 21.00 0.00 1.00 148.67 
50% growth reduction 22.33 0.00 0.33 137.33 
 
% growth reduction indicates that the bacterial culture challenged with the mucus sample grew x% less than the 
average of the control wells.   
An antibacterial unit is defined as the reciprocal of the dilution factor for each well that inhibited growth by x% 
 
Table 3.16 Antibacterial activity for minimal processing assay at 24 hours for all diseases 
calculated in antibacterial units. 
Antibacterial Activity at 24 hours (in Antibacterial Units/ml) 
 S. agalactiae S. iniae A. salmonicida Y. ruckeri 
10% growth reduction 0.00 2732.33 3,625.67 83.33 
20% growth reduction 0.00 2728.33 166.33 82.00 
30% growth reduction 0.00 0.00 412.00 59.00 
40% growth reduction 0.00 0.00 86.67 41.67 
50%  growth reduction 0.00 0.00 20.67 37.33 
 
% growth reduction indicates that the bacterial culture challenged with the mucus sample grew x% less than the 
average of the control wells.   
An antibacterial unit is defined as the reciprocal of the dilution factor for each well that inhibited growth by x% 
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Microtiter Broth Dilution Assay with Sodium Acetate Results 
 
 An additional microtiter broth dilution assay was carried out to evaluate the 
effectiveness of various solvents used in assays which measure antibacterial activities of 
epidermal mucus. An assay recommended by the Department of Marine Biotechnology at 
the University of Tromso, Norway advises the use of sodium acetate (pH 6.0) as a buffer 
in a microtiter dilution assay that measures antibacterial activity of tilapia mucus 
(Mozumder 2005). However, the growth control wells for each disease failed to grow 
with this buffer. The growth control mean for S. agalactiae was -0.05867 at 12 hrs and -
0.02458 at 24 hrs. The growth control mean for S. iniae was -0.003667 at 12 hrs and -
0.01508 at 24 hrs. The growth control mean for A. salmonicida was -0.1295, and the 
growth control mean for Y. ruckeri was -0.01625. This indicates a complete lack of 
culture growth for the entire assay; therefore, antibacterial activity could not be 
calculated. The raw data for three trials of this assay can be found in Appendix A. 
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Microtiter Broth Dilution Assay to Evaluate Buffer Effectiveness Results 
 
 Given the results of the microtiter assay using sodium acetate as a buffer, an 
experiment was conducted which sought to compare the use of sodium acetate buffer to 
phosphate buffered saline. The difference between the 12-hr reading and the 0-hr reading 
for three trials of each buffer with each of the four diseases indicates negative growth for 
all sodium acetate wells and positive growth for PBS wells (Table 3.17). The growth 
means for the sodium acetate test were negative for all diseases, and the growth means 
for all phosphate buffered saline test were positive. This result clearly encourages the use 
of PBS as a buffer in microtiter broth dilution assays. 
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Table 3.17: Growth control means for all diseases grown in sodium acetate or phosphate 
buffered saline. 
Treatment Growth Control Mean 
S. agalactiae + NaAc -0.00425 
S. iniae. + NaAc -0.00167 
A. salmon. + NaAc -0.38017 
Y. ruckeri + NaAc -0.12067 
S. agalactiae + PBS 0.00667 
S. iniae + PBS 0.05 
A. salmonicida + PBS 0.0167 
Y. ruckeri + PBS 0.0417 
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Microtiter Broth Dilution Assay with PBS and Nanosep Centrifugal Filter Results 
 
A final assay was devised which sought to concentrate the protein in the sample to 
see what if any effect this might have on the antibacterial activity measured by the plate 
spectrophotometer. Once the sample was concentrated and desalted with the centrifugal 
filter, absorbance 280 biospectrophotometer readings indicated that protein was present 
both in the rententate and the filtrate. Therefore, the antibacterial assay was run on both 
portions of the sample. It was thought that perhaps the smallest of the antimicrobial 
peptides found in the mucus samples could have been spun into the filtrate..  
The assays carried out with the rententate from this centrifugation filter measured 
no antibacterial activity against any of the four tested diseases (Tables 3.18 and 3.19). 
The results of the assays run on the filtrate (Tables 3.20 and 3.21) illustrate no 
antibacterial activity was present for S. agalactiae, A. salmonicida, or Y. ruckeri at 12 hrs. 
There was; however, significant antibacterial activity measured for A.salmonicida at the 
10% and 20% growth reduction levels with 2,004.33 antibacterial units and 5.33 
antibacterial units respectively.  
This testing method was used on identical samples to the minimal processing 
assay previously discussed. Therefore, the addition of the concentrating filter to the 
process resulted in a reduction in measureable antibacterial activity. This reduction could 
be due to the protein’s exposure to ambient temperatures during the additional time 
needed for processing; however, the samples were maintained on ice and centrifuged at 
4°C. The reduction in activity could also be due to the loss of cross linkages in the mucus 
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during the filtering or the loss of interactions between the larger proteins with the smaller 
peptides. Further research should be undertaken to determine the underlying causes. 
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Table 3.18: Antibacterial activity for centrifugal filter assay retentate sample at 12 hours for all 
diseases calculated in antibacterial units. 
Antibacterial Activity at 12 hours (in Antibacterial Units/ml) 
 S. agalactiae S. iniae A. salmonicida Y. ruckeri 
10% growth reduction 0.00 0.00 0.00 0.00 
20% growth reduction 0.00 0.00 0.00 0.00 
30% growth reduction 0.00 0.00 0.00 0.00 
40% growth reduction 0.00 0.00 0.00 0.00 
50%  growth reduction 0.00 0.00 0.00 0.00 
% growth reduction indicates that the bacterial culture challenged with the mucus sample grew x% less than the 
average of the control wells.   
An antibacterial unit is defined as the reciprocal of the dilution factor for each well that inhibited growth by x% 
 
Table 3.19: Antibacterial activity for centrifugal filter assay retentate sample at 24 hours for all 
diseases calculated in antibacterial units. 
Antibacterial Activity at 24 hours (in Antibacterial Units/ml) 
 S. agalactiae S. iniae A. salmonicida Y. ruckeri 
10% growth reduction 1.00 0.00 0.00 0.67 
20% growth reduction 0.33 0.00 0.00 0.00 
30% growth reduction 0.00 0.00 0.00 0.00 
40% growth reduction 0.00 0.00 0.00 0.00 
50% growth reduction 0.00 0.00 0.00 0.00 
% growth reduction indicates that the bacterial culture challenged with the mucus sample grew x% less than the 
average of the control wells.   
An antibacterial unit is defined as the reciprocal of the dilution factor for each well that inhibited growth by x% 
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Table 3.20: Antibacterial activity for centrifugal filter assay filtrate sample at 12 hours for all 
diseases calculated in antibacterial units. 
Antibacterial Activity at 12 Hours (in Antibacterial Units/ml) 
Sample S. agalactiae S. iniae A. salmonicida Y. ruckeri 
10% growth reduction 0.00 0.00 0.00 0.00 
20% growth reduction 0.00 0.00 0.00 0.00 
30% growth reduction 0.00 0.00 0.00 0.00 
40% growth reduction 0.00 0.00 0.00 0.00 
50%  growth reduction 0.00 0.00 0.00 0.00 
% growth reduction indicates that the bacterial culture challenged with the mucus sample grew x% less than the 
average of the control wells.   
An antibacterial unit is defined as the reciprocal of the dilution factor for each well that inhibited growth by x% 
 
 
 
Table 3.21: Antibacterial activity for centrifugal filter assay filtrate sample at 24 hours for all 
diseases calculated in antibacterial units. 
Antibacterial Activity at 24 Hours (in Antibacterial Units/ml) 
Sample S. agalactiae S. iniae A. salmonicida Y. ruckeri 
10% growth reduction 1.33 0.00 2004.33 5.00 
20% growth reduction 0.33 0.00 5.33 0.00 
30% growth reduction 0.00 0.67 0.00 0.00 
40% growth reduction 0.00 0.00 0.00 0.00 
50% growth reduction 0.00 0.00 0.00 0.00 
% growth reduction indicates that the bacterial culture challenged with the mucus sample grew x% less than the 
average of the control wells.   
An antibacterial unit is defined as the reciprocal of the dilution factor for each well that inhibited growth by x% 
 
 
64 
 
CONCLUSIONS 
  The disk diffusion and spot-on-lawn assays were not successful in measuring 
antibacterial activity unless the sample was diluted into 3% acetic acid. When acetic acid 
was used as a control, it alone resulted in zones of inhibition. Therefore, future studies 
should discontinue use of 3% acetic acid as a solvent. Additional studies should be 
conducted to confirm this finding and to further determine the usefulness of diffusion 
assays on mucus antibacterial testing.  
 The results of the microtiter broth dilution assay also indicate a need to carefully 
examine the role that solvents play in the determination of antibacterial activity. Just as in 
the disk diffusion assay, the addition of sodium acetate (NaAc) to the assay resulted in 
antibacterial activity that was likely the result of the solvent due to the fact that the 
growth control wells, which contained only NaAc and culture, failed to grow. This 
finding was strengthened by an additional assay which compared culture growth with 
phosphate buffered saline and NaAc. Further research should be done to confirm this 
result, and future experimental models should adapt accordingly.  
 In addition, statistical analysis indicates that mucus which has been concentrated 
by a centrifugation filter exhibits less antibacterial activity than that which has not been 
processed beyond simple centrifugation and removal of contaminating bacteria. Using a 
t-test for means comparison, the data collected indicate that against A. salmonicida (Table 
4.1), this most simple method revealed more antibacterial activity for 10%, 20%, 30% 
and 40% for the duration of the assay. Against S. agalactiae (Table 4.2), it detected more 
antibacterial activity for 20-30% at the 12-hour mark but did not provide measure of 
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additional activity at 24 hrs. Against S. iniae (Table 4.2), the simple spin methodology 
provided more measured antibacterial activity for 10-20% for both 12 and 24 hrs. Finally, 
when the simple spin sample was measured against Y. ruckeri, the assay detected more 
antibacterial activity at both time points and for all growth reduction percentages. 
As the simple processed microtiter dilution assay was the only method tested 
which measured any significant antibacterial activity, the biological activity found bears 
further discussion, particularly for the 10% growth reduction level (Table 3.15). Ten 
percent of Y. ruckeri’s growth was inhibited at dilution rates up to 1:1024 (1279.67 
antibacterial units) for the first 12 hrs, which is consistent with the tilapiine ability to 
resist this disease, as it is primarily a pathogen that affects species of salmon (Eissa 
2008). S. agalactiae saw a 10% reduction in growth up to 1:32 dilution during the first 
12-hour period (44.33 antibacterial units) but no change over the second 12 hrs. During 
the first 12-hour period, the mucus sample only reduced A. salmonicida’s growth by 10% 
up to a dilution factor of 1:2; however, by the 24-hour mark, that 10% reduction was 
measured at a dilution factor of 1:2048 (3,625.67 antibacterial units), which indicates that 
the antibacterial activity of the mucus is successful against A. salmonicida but requires a 
longer period of time. Most surprising was the extensive antibacterial activity that the 
mucus samples exhibited against S. iniae with 10% growth reduction up to the 1:2048 
dilution factor at both 12 hrs (2731 antibacterial units) and 24 hrs (2732 antibacterial 
units).  
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When measuring for 20% reduction in growth, the sample was even more limited 
at fighting S. agalactiae at only 40 antibacterial units at the 12-hour measurement and no 
additional reduction of growth was measured at 24 hrs. A. salmonicida had non-
significant reduction of growth for 20% (1.67 antibacterial units) at 12 hrs. Again, the 
mucus was more successful at reducing A. salmonicida at the 24-hour mark (167 
antibacterial units), further indicating that additional time is needed for the mucus to 
successfully fight this bacterium. In contrast, the data indicate that the mucus reduces the 
growth of Y. ruckeri by 20% quickly and completely (1,311.67 antibacterial units) within 
the first 12 hrs then does little to further reduce the growth during the second 12-hour 
period. Finally, as with the 10% reduction rate, S. iniae was significantly reduced for 
20% during both the 12-hour (2,696.67 antibacterial units) and 24-hour (2,728.33 
antibacterial units) time frames. 
The data indicate that the tilapia mucus is much less likely to reduce disease 
growth to higher levels of 30-50%. Y. ruckeri was the most reduced by the mucus 
samples at these levels in the first 12 hrs with 30% reduction by 586 antibacterial units, 
40% reduction by 148.67 antibacterial units, and 50% reduction by 137.33 antibacterial 
units. During the second 12-hour period, the mucus sample was less able to reduce Y. 
ruckeri’s growth to 30% (59.00 antibacterial units), 40% (41.67 antibacterial units), and 
50% (37.33 antibacterial units). The mucus failed to reduce S. iniae at rates of 30-50% at 
all, and it only reduced S. agalactiae in the first 12 hrs to 30% (29 antibacterial units), 
40% (21 antibacterial units), and 50% (22.33 antibacterial units). The sample’s ability to 
kill A. salmonicida to higher levels (30-50%) continues the trend of limited potency by 
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the 12-hour mark with only 1 antibacterial unit for 30% and 40%, and 0.33 antibacterial 
unit for 50% reduction. However, by 24 hrs, those numbers had increased exponentially 
to 412 antibacterial units for 30% reduction, 86.67 antibacterial units for 40%, and 20.67 
antibacterial units for 50% reduction. Overall, the mucus with limited processing was 
able to successfully defend against all four bacterial cultures, though S. agalactiae to a 
lesser degree. This result is consistent with reports of the virulence of S. agalactiae. 
When the dilution factor is isolated as a variable with the standard of inhibition 
simply being whether it grew more or less than the Control, it becomes apparent that at 
certain dilution factors, the addition of the mucus sample may have aided in the growth of 
the bacteria culture. This is particularly true for the Streptococcus species (Figures 4.1 
and 4.2). At the 12-hour reading, S. agalactiae was significantly different from control at 
the 1:64, 1:128, 1:256, 1:512 dilution factors, and each of these data points showed an 
increase in colony growth with the addition of the mucus. It is possible at this low level 
of antibacterial activity that the bacteria are able to feed off of the sugar portion of the 
glycoprotein. Similar behavior has been observed in bacteria which feed off of the mucus 
within the intestines of mice (Berry 2013). However, at the 24-hour reading for S. 
agalactiae, 1:4, 1:8, and 1:64 also showed the bacteria appear to benefit from the addition 
of the mucus. In contrast, S. iniae’s 12-hour reading (Figure 4.2) included significant 
differences from control at dilution factors 1:1, 1:8, 1:16, 1:32, 1:64, 1:128, 1:512, and 
1:2048. Each of these data points was less than the control mean; therefore, statistically 
significant growth reduction occurred during this time period. The 24-hour reading, 
however, indicates a significant difference at 1:1, 1:2, 1:4, 1:64, and each of these is 
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above the growth mean, indicating that the culture grew better in the mucus wells than in 
the control wells. More research needs to be done to determine the underlying causes of 
this result.  
When looking at the dilution factor treatments for A. salmonicida and Y. ruckeri 
(Figures 4.3 and 4.4), the most apparent finding is that A. salmonicida does significant 
growing during the first 12-hour period and is inhibited during the second 12-hour period. 
Y. ruckeri does the opposite, rebounding in the second phase after inhibition in the first. If 
one looks at specific dilution factors, during the first 12 hrs, A. salmonicida was 
significantly different from the Control at the 1:2048 dilution where it grew better than 
the Control. At the 24-hour reading, A. salmonicida was only different from the Control 
at the 1:32 dilution point where it was inhibited below the levels of the Control. Y. 
ruckeri was only different than the control for the 1:8 dilution factor during the second 
12-hour growth period, and it grew significantly less than Control. 
Initially, it was thought that the microtiter broth dilution assay failed to measure 
significant antibacterial activity at all; however, the wrong question was being asked of 
the data. Early experiments involved calculating only antibacterial activity that reached 
the level of 50% growth reduction; this resulted in findings that were essentially hidden 
in the numbers. Once levels lower than 50% were analyzed, the antibacterial activity 
became apparent. These findings reinforce the necessity for further development of a 
highly sensitive test which takes into account real world conditions. Additionally, further 
research is needed into both the general and specific modes in which antimicrobial 
compounds found in tilapia mucus attack varying species of bacteria.   
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Table 4.1: Mean Comparison (via t-test) of antibacterial activity (in antibacterial units) 
against A. salmonicida and Y. ruckeri at 12 and 24 hours using three processing methods   
Disease 
Name 
Time 
(Hours) 
Growth 
Reduction 
Method 1 
Mean1 
Method 2 
Mean2 
Method 3 
Mean3 
A. salmonicida 12 10% 2.33A 0.00B 0.00B 
A. salmonicida 12 20% 1.67A 0.00B 0.00B 
A. salmonicida 12 30% 1.00A 0.00B 0.00B 
A. salmonicida 12 40% 1.00A 0.00B 0.00B 
A. salmonicida 12 50% 0.33A 0.00A 0.00A 
A. salmonicida 24 10% 3602.67A 2004.33AB 0.00B 
A. salmonicida 24 20% 2642.67A 0.00B 0.00B 
A. salmonicida 24 30% 2338.00A 0.00B 0.00B 
A. salmonicida 24 40% 77.33A 0.00B 0.00B 
A. salmonicida 24 50% 20.67A 0.00B 0.00B 
Y. ruckeri 12 10% 1654.00A 0.00B 0.00B 
Y. ruckeri 12 20% 1311.67A 0.00B 0.00B 
Y. ruckeri 12 30% 586.00A 0.00B 0.00B 
Y. ruckeri 12 40% 148.67A 0.00B 0.00B 
Y. ruckeri 12 50% 137.33A 0.00B 0.00B 
Y. ruckeri 24 10% 83.33A 5.00B 0.67B 
Y. ruckeri 24 20% 82.00A 0.00B 0.00B 
Y. ruckeri 24 30% 59.00A 0.00B 0.00B 
Y. ruckeri 24 40% 41.67A 0.00B 0.00B 
Y. ruckeri 24 50% 37.33A 0.00B 0.00B 
1Method 1: Microtiter Broth Dilution Assay/Minimal Sample Processing 
2Method 2: Microtiter Broth Dilution Assay with PBS and Nanosep Centrifugal Filter for Retentate 
3Method 3: Microtiter Broth Dilution Assay with PBS and Nanosep Centrifugal Filter for Filtrate 
 
Means not connected by the same letter (A/B) are significantly different and are highlighted in yellow. 
Statistical analysis was completed using JMP software (Appendix B) 
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Table 4.2: Mean Comparison (via t-test) of antibacterial activity (in antibacterial units) 
against S. agalactiae and S.iniae at 12 and 24 hours using three processing methods   
 
Disease 
Name 
Time 
(Hours) 
Growth 
Reduction 
Method 1 
Mean1 
Method 2 
Mean2 
Method 3 
Mean3 
S. agalactiae 12 10% 23.00A 0.00A 0.00A 
S. agalactiae 12 20% 34.67A 0.00B 0.00B 
S. agalactiae 12 30% 29.00A 0.00B 0.00B 
S. agalactiae 12 40% 26.67A 0.00A 0.00A 
S. agalactiae 12 50% 29.33A 0.00A 0.00A 
S. agalactiae 24 10% 1.00A 0.00A 0.00A 
S. agalactiae 24 20% 0.33A 0.00A 0.00A 
S. agalactiae 24 30% 0.00A 0.00A 0.00A 
S. agalactiae 24 40% 0.00A 0.00A 0.00A 
S. agalactiae 24 50% 0.00A 0.00A 0.00A 
S. iniae 12 10% 2731.67A 0.00B 0.00B 
S. iniae 12 20% 2716.67A 0.00B 0.00B 
S. iniae 12 30% 0.00A 0.00A 0.00A 
S. iniae 12 40% 0.00A 0.00A 0.00A 
S. iniae 12 50% 0.00A 0.00A 0.00A 
S. iniae 24 10% 2732.33A 0.00B 0.00B 
S. iniae 24 20% 2728.00A 0.00B 0.00B 
S. iniae 24 30% 0.67A 0.00A 0.00A 
S. iniae 24 40% 0.00A 0.00A 0.00A 
S. iniae 24 50% 0.00A 0.00A 0.00A 
 
1Method 1: Microtiter Broth Dilution Assay/Minimal Sample Processing 
2Method 2: Microtiter Broth Dilution Assay with PBS and Nanosep Centrifugal Filter for Retentate 
3Method 3: Microtiter Broth Dilution Assay with PBS and Nanosep Centrifugal Filter for Filtrate 
 
Means not connected by the same letter (A/B) are significantly different and are highlighted. 
Statistical analysis was completed using JMP software (Appendix B) 
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Figure 4.1: S. agalactiae growth measured after 12 hours and 24 hours using the 
minimally processed sample microtiter broth plate assay with dilution factor as an 
isolated variable. 
 
 
Growth Index is defined as a ratio of the plate reading to an average of the entire zero hour plate. 
Asterisk indicates statistical significance with a 95% confidence level 
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Figure 4.2: S. iniae growth measured after 12 hours and 24 hours using the minimally 
processed sample microtiter broth plate assay with dilution factor as an isolated variable. 
 
 
 
Growth Index is defined as a ratio of the plate reading to an average of the entire zero hour plate. 
Asterisk indicates statistical significance with a 95% confidence level 
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Figure 4.3: A. salmonicida growth measured after 12 hours and 24 hours using the 
minimally processed sample microtiter broth plate assay with dilution factor as an 
isolated variable. 
 
 
 
 
Growth Index is defined as a ratio of the plate reading to an average of the entire zero hour plate. 
Asterisk indicates statistical significance with a 95% confidence level 
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Figure 4.3: A. salmonicida growth measured after 12 hours and 24 hours using the 
minimally processed sample microtiter broth plate assay with dilution factor as an 
isolated variable. 
 
 
 
 
Growth Index is defined as a ratio of the plate reading to an average of the entire zero hour plate. 
Asterisk indicates statistical significance with a 95% confidence level 
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APPENDIX A: RAW DATA 
 
Table A.1: Zero-hour spectrophotometer reading of microtiter assay with minimal processing for S. agalactiae and S. iniae 
  
  
0 Hr 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
S. agalactiae + sample dilution 0.042 0.041 0.041 0.04 0.04 0.04 0.04 0.04 0.041 0.041 0.04 0.04 
S. agalactiae + sample dilution 0.042 0.041 0.04 0.04 0.039 0.039 0.039 0.041 0.04 0.04 0.042 0.04 
S. agalactiae + sample dilution 0.042 0.041 0.041 0.04 0.039 0.039 0.039 0.041 0.041 0.042 0.039 0.04 
S. iniae + sample dilution 0.043 0.043 0.041 0.041 0.04 0.041 0.04 0.042 0.041 0.04 0.043 0.04 
S. iniae + sample dilution 0.043 0.042 0.041 0.041 0.04 0.041 0.04 0.041 0.041 0.04 0.04 0.04 
S.iniae + sample dilution 0.042 0.042 0.042 0.04 0.04 0.04 0.04 0.04 0.041 0.04 0.039 0.039 
S. agalactiae  
GROWTH CONTROL 0.042 0.039 0.039 0.039 0.039 0.04 0.039 0.04 0.04 0.04 0.04 0.04 
S. iniae  
GROWTH CONTROL 0.041 0.039 0.043 0.045 0.04 0.04 0.04 0.041 0.041 0.041 0.039 0.041 
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Table A.2: Twelve-hour spectrophotometer reading of microtiter assay with minimal processing for S. agalactiae and S. iniae 
 
  
12 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
S. agalactiae + sample dilution 0.322 0.212 0.37 0.278 0.52 0.316 0.818 0.69 0.562 0.437 0.369 0.272 
S. agalactiae + sample dilution 0.345 0.1 0.076 0.387 0.306 0.695 0.511 0.599 0.64 0.6 0.454 0.319 
S. agalactiae + sample dilution 0.244 0.266 0.241 0.654 0.149 0.255 0.531 0.62 0.536 0.594 0.411 0.375 
S. iniae + sample dilution 0.15 0.239 0.249 0.199 0.275 0.229 0.114 0.081 0.071 0.183 0.067 0.056 
S. iniae + sample dilution 0.169 0.393 0.217 0.172 0.203 0.095 0.116 0.077 0.074 0.089 0.063 0.061 
S.iniae + sample dilution 0.2 0.341 0.23 0.07 0.065 0.106 0.084 0.096 0.062 0.156 0.059 0.117 
S. agalactiae  
GROWTH CONTROL 0.238 0.408 0.341 0.354 0.446 0.443 0.409 0.409 0.477 0.606 0.649 0.412 
S. iniae  
GROWTH CONTROL 0.047 0.044 0.052 0.054 0.124 0.058 0.06 0.07 0.055 0.05 0.055 0.047 
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Table A.3: Twenty-four-hour spectrophotometer reading of microtiter assay with minimal processing for S. agalactiae and S. 
iniae 
 
  
24 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
S. agalactiae + sample dilution 0.4 0.308 0.586 0.396 0.356 0.077 0.349 0.329 0.281 0.273 0.28 0.273 
S. agalactiae + sample dilution 0.392 0.246 0.309 0.5 0.114 0.4 0.515 0.405 0.327 0.285 0.283 0.26 
S. agalactiae + sample dilution 0.37 0.311 0.379 0.472 0.105 0.198 0.563 0.428 0.37 0.291 0.279 0.271 
S. iniae + sample dilution 0.284 0.297 0.418 0.245 0.271 0.245 0.059 0.115 0.07 0.21 0.064 0.084 
S. iniae + sample dilution 0.284 0.497 0.314 0.167 0.234 0.076 0.274 0.128 0.113 0.166 0.133 0.07 
S.iniae + sample dilution 0.172 0.458 0.309 0.11 0.095 0.111 0.18 0.128 0.071 0.139 0.123 0.13 
S. agalactiae  
GROWTH CONTROL 0.26 0.263 0.255 0.259 0.286 0.269 0.272 0.282 0.258 0.252 0.241 0.247 
S. iniae  
GROWTH CONTROL 0.09 0.065 0.076 0.092 0.069 0.086 0.068 0.083 0.111 0.08 0.066 0.075 
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Table A.4: Zero-hour spectrophotometer reading of microtiter assay with minimal processing for A. salmonicida and Y. ruckeri 
 
  
0 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
A. salmon. + sample dilution 0.044 0.042 0.04 0.04 0.039 0.054 0.041 0.04 0.04 0.045 0.04 0.04 
A. salmon. + sample dilution 0.043 0.041 0.04 0.039 0.039 0.04 0.04 0.041 0.04 0.043 0.04 0.04 
A. salmon. + sample dilution 0.042 0.041 0.041 0.04 0.04 0.041 0.04 0.041 0.041 0.043 0.04 0.04 
Y. ruckeri + sample dilution 0.044 0.041 0.042 0.04 0.041 0.04 0.041 0.042 0.041 0.04 0.04 0.041 
Y. ruckeri + sample dilution 0.043 0.043 0.041 0.041 0.041 0.041 0.041 0.042 0.041 0.04 0.041 0.041 
Y. ruckeri + sample dilution 0.047 0.045 0.043 0.299 0.042 0.042 0.039 0.041 0.039 0.04 0.04 0.04 
A. salmonicida  
GROWTH CONTROL 0.04 0.04 0.041 0.04 0.04 0.04 0.04 0.04 0.04 0.044 0.04 0.04 
Y. ruckeri 
GROWTH CONTROL 0.04 0.04 0.043 0.04 0.04 0.04 0.04 0.04 0.038 0.044 0.04 0.041 
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Table A.5: Twelve-hour spectrophotometer reading of microtiter assay with minimal processing for A. salmonicida and Y. 
ruckeri 
 
  
12 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
A. salmon. + sample dilution 0.18 0.211 0.271 0.271 0.274 0.084 0.349 0.266 0.31 0.088 0.312 0.417 
A. salmon. + sample dilution 0.163 0.243 0.311 0.285 0.321 0.295 0.23 0.211 0.265 0.349 0.295 0.414 
A. salmon. + sample dilution 0.153 0.269 0.354 0.238 0.367 0.392 0.201 0.195 0.234 0.325 0.262 0.378 
Y. ruckeri + sample dilution 0.195 0.269 0.268 0.259 0.293 0.222 0.161 0.247 0.171 0.21 0.255 0.345 
Y. ruckeri + sample dilution 0.179 0.27 0.289 0.251 0.358 0.299 0.322 0.303 0.219 0.215 0.246 0.376 
Y. ruckeri + sample dilution 0.236 0.276 0.122 0.332 0.138 0.173 0.09 0.282 0.314 0.317 0.241 0.414 
A. salmonicida  
GROWTH CONTROL 0.347 0.296 0.274 0.228 0.23 0.257 0.234 0.258 0.242 0.255 0.315 0.355 
Y. ruckeri 
GROWTH CONTROL 0.393 0.267 0.311 0.312 0.319 0.32 0.298 0.268 0.291 0.287 0.263 0.282 
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Table A.6: Twenty-four-hour spectrophotometer reading of microtiter assay with minimal processing for A. salmonicida and Y. 
ruckeri 
 
 
 
24 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
A. salmon. + sample dilution 0.287 0.468 0.309 0.288 0.26 0.076 0.325 0.574 0.506 0.072 0.603 0.323 
A. salmon. + sample dilution 0.456 0.359 0.482 0.326 0.344 0.339 0.464 0.486 0.571 0.458 0.533 0.378 
A. salmon. + sample dilution 0.268 0.408 0.404 0.367 0.463 0.327 0.514 0.432 0.491 0.51 0.544 0.408 
Y. ruckeri + sample dilution 0.473 0.424 0.39 0.35 0.377 0.309 0.468 0.666 0.542 0.684 0.664 0.508 
Y. ruckeri + sample dilution 0.321 0.438 0.663 0.258 0.391 0.534 0.681 0.632 0.647 0.681 0.715 0.432 
Y. ruckeri + sample dilution 0.589 0.59 0.323 0.314 0.381 0.586 0.127 0.617 0.627 0.639 0.53 0.394 
A. salmonicida  
GROWTH CONTROL 0.591 0.674 0.672 0.625 0.623 0.675 0.638 0.644 0.609 0.41 0.718 0.411 
Y. ruckeri 
GROWTH CONTROL 0.866 0.74 0.43 0.497 0.542 0.56 0.653 0.651 0.595 0.666 0.485 0.345 
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Table A.7: Zero-hour spectrophotometer reading of microtiter assay with sodium acetate for S. agalactiae and S. iniae 
 
  
0 Hr 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
S. agalactiae + sample dilution 0.307 0.308 0.281 0.288 0.287 0.282 0.29 0.286 0.289 0.287 0.286 0.287 
S. agalactiae + sample dilution 0.32 0.313 0.28 0.277 0.312 0.29 0.29 0.292 0.289 0.288 0.293 0.283 
S. agalactiae + sample dilution 0.321 0.329 0.264 0.291 0.295 0.286 0.292 0.288 0.293 0.287 0.29 0.285 
S. iniae + sample dilution 0.269 0.285 0.262 0.263 0.263 0.263 0.249 0.25 0.261 0.243 0.234 0.255 
S. iniae + sample dilution 0.257 0.282 0.265 0.269 0.262 0.27 0.267 0.26 0.264 0.247 0.235 0.258 
S.iniae + sample dilution 0.264 0.286 0.265 0.263 0.27 0.274 0.258 0.266 0.264 0.256 0.237 0.255 
S. agalactiae  
GROWTH CONTROL 0.267 0.276 0.277 0.268 0.285 0.274 0.275 0.275 0.282 0.276 0.28 0.277 
S. iniae  
GROWTH CONTROL 0.251 0.25 0.248 0.261 0.248 0.249 0.264 0.257 0.262 0.286 0.26 0.246 
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Table A.8: Twelve-hour spectrophotometer reading of microtiter assay with sodium acetate for S. agalactiae and S. iniae 
 
  
12 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
S. agalactiae + sample dilution 0.744 0.619 0.504 0.538 0.536 0.518 0.541 0.548 0.491 0.464 0.515 0.543 
S. agalactiae + sample dilution 0.774 0.47 0.471 0.372 0.762 0.478 0.465 0.443 0.441 0.448 0.451 0.453 
S. agalactiae + sample dilution 0.739 0.609 0.408 0.483 0.48 0.44 0.417 0.421 0.407 0.424 0.397 0.438 
S. iniae + sample dilution 0.343 0.301 0.281 0.269 0.272 0.261 0.253 0.26 0.263 0.254 0.235 0.244 
S. iniae + sample dilution 0.335 0.268 0.281 0.279 0.271 0.285 0.265 0.267 0.271 0.261 0.241 0.257 
S.iniae + sample dilution 0.342 0.279 0.28 0.278 0.277 0.275 0.257 0.259 0.263 0.258 0.244 0.25 
S. agalactiae  
GROWTH CONTROL 0.255 0.363 0.189 0.4 0.412 0.394 0.387 0.381 0.402 0.397 0.397 0.401 
S. iniae  
GROWTH CONTROL 0.276 0.259 0.252 0.269 0.258 0.257 0.278 0.25 0.262 0.293 0.261 0.255 
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Table A.9: Twenty-four-hour spectrophotometer reading of microtiter assay with sodium acetate for S. agalactiae and S. iniae 
 
  
24 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
S. agalactiae + sample dilution 0.791 0.605 0.562 0.586 0.558 0.555 0.585 0.577 0.538 0.52 0.512 0.566 
S. agalactiae + sample dilution 0.85 0.515 0.369 0.461 0.548 0.5 0.524 0.479 0.485 0.504 0.487 0.439 
S. agalactiae + sample dilution 0.772 0.6 0.456 0.558 0.515 0.491 0.449 0.476 0.431 0.451 0.409 0.429 
S. iniae + sample dilution 0.369 0.299 0.28 0.27 0.27 0.261 0.25 0.254 0.252 0.232 0.21 0.233 
S. iniae + sample dilution 0.36 0.266 0.282 0.277 0.28 0.257 0.253 0.255 0.264 0.235 0.226 0.241 
S.iniae + sample dilution 0.374 0.28 0.277 0.278 0.274 0.271 0.252 0.245 0.25 0.243 0.228 0.239 
S. agalactiae  
GROWTH CONTROL 0.336 0.343 0.441 0.446 0.469 0.392 0.368 0.347 0.376 0.345 0.28 0.285 
S. iniae  
GROWTH CONTROL 0.253 0.241 0.237 0.255 0.243 0.242 0.263 0.239 0.246 0.281 0.247 0.242 
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Table A.10: Zero-hour spectrophotometer reading of microtiter assay with sodium acetate for A. salmonicida and Y. ruckeri 
 
  
0 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
A. salmon. + sample dilution 0.237 0.277 0.311 0.315 0.321 0.314 0.318 0.268 0.308 0.319 0.318 0.322 
A. salmon. + sample dilution 0.427 0.251 0.313 0.301 0.314 0.313 0.319 0.319 0.314 0.326 0.33 0.327 
A. salmon. + sample dilution 0.249 0.261 0.307 0.304 0.319 0.314 0.319 0.32 0.313 0.318 0.322 0.327 
Y. ruckeri + sample dilution 0.268 0.248 0.259 0.261 0.269 0.275 0.271 0.274 0.274 0.276 0.275 0.261 
Y. ruckeri + sample dilution 0.246 0.249 0.258 0.268 0.271 0.274 0.27 0.25 0.268 0.275 0.269 0.255 
Y. ruckeri + sample dilution 0.248 0.261 0.271 0.267 0.267 0.274 0.275 0.275 0.274 0.281 0.269 0.27 
A. salmonicida  
GROWTH CONTROL 0.242 0.233 0.275 0.291 0.314 0.312 0.336 0.313 0.306 0.293 0.305 0.319 
Y. ruckeri 
GROWTH CONTROL 0.255 0.259 0.278 0.255 0.233 0.265 0.27 0.269 0.262 0.273 0.265 0.249 
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Table A.11: Twelve-hour spectrophotometer reading of microtiter assay with sodium acetate for A. salmonicida and Y. ruckeri 
 
 
  
12 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
A. salmon. + sample dilution 0.264 0.263 0.24 0.241 0.221 0.2 0.184 0.234 0.173 0.215 0.199 0.195 
A. salmon. + sample dilution 0.271 0.271 0.246 0.22 0.217 0.191 0.201 0.188 0.175 0.193 0.193 0.2 
A. salmon. + sample dilution 0.279 0.271 0.242 0.221 0.213 0.21 0.186 0.192 0.183 0.183 0.194 0.18 
Y. ruckeri + sample dilution 0.31 0.281 0.277 0.272 0.263 0.274 0.261 0.259 0.27 0.265 0.264 0.245 
Y. ruckeri + sample dilution 0.291 0.276 0.275 0.277 0.272 0.258 0.263 0.254 0.286 0.264 0.273 0.248 
Y. ruckeri + sample dilution 0.302 0.281 0.275 0.271 0.273 0.267 0.258 0.266 0.271 0.258 0.273 0.267 
A. salmonicida  
GROWTH CONTROL 0.116 0.114 0.153 0.156 0.196 0.189 0.186 0.184 0.182 0.154 0.168 0.187 
Y. ruckeri 
GROWTH CONTROL 0.228 0.246 0.256 0.233 0.225 0.261 0.254 0.259 0.247 0.244 0.243 0.242 
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Table A.12: Twenty-four-hour spectrophotometer reading of microtiter assay with sodium acetate for A. salmonicida and Y. 
ruckeri 
  
24 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
A. salmon. + sample dilution 0.267 0.26 0.201 0.202 0.194 0.163 0.125 0.249 0.145 0.128 0.13 0.139 
A. salmon. + sample dilution 0.272 0.27 0.208 0.184 0.2 0.142 0.134 0.135 0.138 0.131 0.147 0.12 
A. salmon. + sample dilution 0.28 0.232 0.208 0.183 0.181 0.147 0.127 0.136 0.124 0.142 0.139 0.117 
Y. ruckeri + sample dilution 0.311 0.282 0.284 0.281 0.274 0.281 0.259 0.264 0.265 0.255 0.26 0.252 
Y. ruckeri + sample dilution 0.298 0.281 0.286 0.289 0.276 0.262 0.255 0.276 0.275 0.25 0.261 0.25 
Y. ruckeri + sample dilution 0.312 0.281 0.281 0.28 0.279 0.268 0.257 0.263 0.259 0.256 0.266 0.266 
A. salmonicida  
GROWTH CONTROL 0.093 0.084 0.099 0.102 0.129 0.127 0.131 0.125 0.12 0.105 0.104 0.115 
Y. ruckeri 
GROWTH CONTROL 0.245 0.252 0.249 0.231 0.224 0.245 0.241 0.239 0.233 0.24 0.249 0.232 
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Table A.13: Zero-hour spectrophotometer readings of all diseases grown in sodium acetate (NaAc) or phosphate buffered 
saline (PBS). 
 
  
0 Hr             
S. agalactiae + NaAc 0.057 0.056 0.058 0.055 0.056 0.056 0.057 0.057 0.056 0.056 0.055 0.058 
S. iniae. + NaAc 0.053 0.053 0.05 0.053 0.053 0.053 0.054 0.053 0.052 0.053 0.053 0.053 
A. salmon. + NaAc 0.286 0.574 0.564 0.562 0.696 0.742 0.722 0.648 0.61 0.609 0.421 0.292 
Y. ruckeri + NaAc 0.284 0.468 0.476 0.4 0.362 0.34 0.274 0.349 0.32 0.745 0.287 0.329 
S. agalactiae + PBS 0.044 0.044 0.044 0.044 0.044 0.044 0.044 0.045 0.044 0.045 0.045 0.045 
S. iniae + PBS 0.044 0.044 0.045 0.044 0.044 0.045 0.045 0.044 0.044 0.043 0.044 0.046 
A. salmonicida + PBS 0.045 0.044 0.044 0.043 0.041 0.044 0.046 0.044 0.045 0.044 0.045 0.046 
Y. ruckeri + PBS 0.044 0.045 0.046 0.044 0.044 0.044 0.044 0.044 0.044 0.047 0.045 0.044 
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Table A.14: Twelve-hour spectrophotometer readings of all diseases grown in sodium acetate or phosphate buffered saline. 
 
 
  
12 Hrs             
S. agalactiae + NaAc 0.052 0.053 0.052 0.053 0.052 0.053 0.053 0.052 0.052 0.052 0.053 0.049 
S. iniae. + NaAc 0.056 0.053 0.053 0.053 0.053 0.052 0.052 0.052 0.052 0.053 0.053 0.053 
A. salmon. + NaAc 0.244 0.177 0.181 0.188 0.177 0.187 0.16 0.159 0.154 0.175 0.162 0.2 
Y. ruckeri + NaAc 0.262 0.363 0.354 0.289 0.264 0.295 0.298 0.207 0.168 0.214 0.206 0.266 
S. agalactiae + PBS 0.045 0.045 0.045 0.045 0.045 0.046 0.045 0.045 0.045 0.046 0.044 0.044 
S. iniae + PBS 0.045 0.045 0.045 0.045 0.045 0.046 0.045 0.044 0.045 0.045 0.044 0.044 
A. salmonicida + PBS 0.045 0.045 0.044 0.045 0.044 0.044 0.045 0.044 0.044 0.044 0.044 0.045 
Y. ruckeri + PBS 0.045 0.044 0.047 0.044 0.045 0.044 0.044 0.044 0.045 0.047 0.045 0.046 
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Table A.15: Difference between 12 h and 0 hr spectrophotometer readings of all diseases grown in sodium acetate or 
phosphate buffered saline. 
 
 
 
 
  
12 Hrs – 0 Hrs             
S. agalactiae + NaAc -0.005 -0.003 -0.006 -0.002 -0.004 -0.003 -0.004 -0.005 -0.004 -0.004 -0.002 -0.009 
S. iniae. + NaAc 0.003 0 0.003 0 0 -0.001 -0.002 -0.001 0 0 0 0 
A. salmon. + NaAc -0.042 -0.397 -0.383 -0.374 -0.519 -0.555 -0.562 -0.489 -0.456 -0.434 -0.259 -0.092 
Y. ruckeri + NaAc -0.022 -0.105 -0.122 -0.111 -0.098 -0.045 0.024 -0.142 -0.152 -0.531 -0.081 -0.063 
S. agalactiae + PBS 0.001 0.001 0.001 0.001 0.001 0.002 0.001 0 0.001 0.001 -0.001 -0.001 
S. iniae + PBS 0.001 0.001 0 0.001 0.001 0.001 0 0 0.001 0.002 0 -0.002 
A. salmonicida + PBS 0 0.001 0 0.002 0.003 0 -0.001 0 -0.001 0 -0.001 -0.001 
Y. ruckeri + PBS 0.001 -0.001 0.001 0 0.001 0 0 0 0.001 0 0 0.002 
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Table A.16: Zero-hour spectrophotometer reading of microtiter assay retentate sample with centrifugal filter for S. agalactiae 
and S. iniae  
 
  
0 Hr 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
S. agalactiae + sample dilution 0.067 0.063 0.062 0.061 0.059 0.059 0.059 0.059 0.059 0.059 0.059 0.059 
S. agalactiae + sample dilution 0.07 0.064 0.062 0.06 0.059 0.059 0.059 0.058 0.059 0.06 0.059 0.059 
S. agalactiae + sample dilution 0.07 0.07 0.063 0.06 0.06 0.06 0.059 0.059 0.059 0.059 0.058 0.06 
S. iniae + sample dilution 0.07 0.067 0.063 0.063 0.062 0.061 0.062 0.061 0.061 0.06 0.06 0.06 
S. iniae + sample dilution 0.075 0.065 0.064 0.063 0.063 0.062 0.063 0.061 0.062 0.061 0.061 0.06 
S.iniae + sample dilution 0.07 0.065 0.065 0.063 0.062 0.061 0.062 0.061 0.061 0.06 0.061 0.06 
S. agalactiae  
GROWTH CONTROL 0.06 0.059 0.061 0.059 0.06 0.06 0.06 0.06 0.06 0.06 0.059 0.06 
S. iniae  
GROWTH CONTROL 0.061 0.06 0.063 0.061 0.061 0.062 0.061 0.06 0.061 0.063 0.06 0.06 
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Table A.17: Twelve-hour spectrophotometer reading of microtiter assay retentate sample with centrifugal filter for S. 
agalactiae and S. iniae 
 
  
12 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
S. agalactiae + sample dilution 0.726 0.639 0.64 0.631 0.645 0.644 0.653 0.651 0.645 0.638 0.629 0.664 
S. agalactiae + sample dilution 0.754 0.656 0.625 0.649 0.626 0.637 0.636 0.609 0.646 0.661 0.666 0.64 
S. agalactiae + sample dilution 0.643 0.653 0.627 0.64 0.635 0.643 0.623 0.613 0.637 0.624 0.628 0.668 
S. iniae + sample dilution 0.491 0.518 0.522 0.547 0.521 0.523 0.48 0.481 0.462 0.489 0.466 0.507 
S. iniae + sample dilution 0.502 0.5 0.536 0.537 0.492 0.491 0.517 0.475 0.474 0.477 0.473 0.534 
S.iniae + sample dilution 0.506 0.512 0.502 0.557 0.526 0.469 0.493 0.485 0.473 0.468 0.453 0.548 
S. agalactiae  
GROWTH CONTROL 0.627 0.64 0.647 0.578 0.643 0.64 0.665 0.628 0.653 0.653 0.653 0.667 
S. iniae  
GROWTH CONTROL 0.551 0.486 0.467 0.39 0.488 0.456 0.451 0.467 0.386 0.423 0.4 0.506 
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Table A.18: Twenty-four-hour spectrophotometer reading of microtiter assay retentate sample with centrifugal filter for S. 
agalactiae and S. iniae 
 
  
24 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
S. agalactiae + sample dilution 0.638 0.62 0.744 0.778 0.794 0.823 0.782 0.768 0.763 0.74 0.736 0.742 
S. agalactiae + sample dilution 1.471 0.718 0.724 0.742 0.715 0.744 0.772 0.726 0.763 0.766 0.751 0.738 
S. agalactiae + sample dilution 0.606 0.687 0.818 0.729 0.777 0.775 0.744 0.724 0.738 0.734 0.727 0.778 
S. iniae + sample dilution 0.523 0.537 0.546 0.566 0.536 0.542 0.499 0.5 0.487 0.505 0.497 0.544 
S. iniae + sample dilution 0.533 0.519 0.557 0.557 0.529 0.523 0.543 0.5 0.499 0.5 0.499 0.57 
S.iniae + sample dilution 0.586 0.533 0.515 0.579 0.842 0.509 0.527 0.522 0.514 0.509 0.494 0.587 
S. agalactiae  
GROWTH CONTROL 0.733 0.735 0.77 0.691 0.755 0.758 0.759 0.731 0.756 0.74 0.723 0.731 
S. iniae  
GROWTH CONTROL 0.603 0.545 0.517 0.43 0.532 0.493 0.484 0.505 0.418 0.447 0.443 0.538 
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Table A.19: Zero-hour spectrophotometer reading of microtiter assay retentate sample with centrifugal filter for A. salmonicida 
and Y. ruckeri 
 
  
0 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
A. salmon. + sample dilution 0.072 0.069 0.067 0.064 0.063 0.064 0.064 0.064 0.064 0.063 0.063 0.064 
A. salmon. + sample dilution 0.071 0.069 0.067 0.065 0.064 0.063 0.064 0.063 0.064 0.064 0.064 0.064 
A. salmon. + sample dilution 0.073 0.069 0.067 0.065 0.065 0.064 0.063 0.064 0.063 0.063 0.063 0.064 
Y. ruckeri + sample dilution 0.072 0.07 0.067 0.066 0.066 0.065 0.065 0.066 0.065 0.066 0.066 0.066 
Y. ruckeri + sample dilution 0.075 0.069 0.067 0.066 0.066 0.066 0.067 0.067 0.066 0.065 0.065 0.065 
Y. ruckeri + sample dilution 0.071 0.07 0.067 0.066 0.066 0.065 0.066 0.066 0.065 0.065 0.065 0.065 
A. salmonicida  
GROWTH CONTROL 0.063 0.063 0.063 0.064 0.063 0.064 0.064 0.063 0.064 0.064 0.064 0.064 
Y. ruckeri 
GROWTH CONTROL 0.056 0.064 0.066 0.065 0.065 0.064 0.063 0.065 0.064 0.068 0.066 0.066 
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Table A.20: Twelve-hour spectrophotometer reading of microtiter assay retentate sample with centrifugal filter for A. 
salmonicida and Y. ruckeri 
 
  
12 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
A. salmon. + sample dilution 0.371 0.336 0.325 0.324 0.298 0.322 0.305 0.286 0.279 0.291 0.291 0.287 
A. salmon. + sample dilution 0.299 0.312 0.297 0.294 0.29 0.279 0.278 0.286 0.281 0.257 0.281 0.264 
A. salmon. + sample dilution 0.334 0.301 0.288 0.294 0.296 0.292 0.271 0.283 0.284 0.24 0.276 0.294 
Y. ruckeri + sample dilution 0.374 0.331 0.338 0.362 0.347 0.342 0.289 0.326 0.298 0.354 0.327 0.279 
Y. ruckeri + sample dilution 0.327 0.343 0.329 0.335 0.335 0.34 0.331 0.327 0.326 0.35 0.316 0.317 
Y. ruckeri + sample dilution 0.339 0.31 0.312 0.343 0.316 0.332 0.345 0.324 0.318 0.34 0.327 0.309 
A. salmonicida  
GROWTH CONTROL 0.277 0.248 0.245 0.256 0.252 0.25 0.265 0.23 0.263 0.252 0.27 0.275 
Y. ruckeri 
GROWTH CONTROL 0.292 0.336 0.347 0.34 0.331 0.357 0.351 0.331 0.321 0.309 0.308 0.303 
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Table A.21: Twenty-four-hour spectrophotometer reading of microtiter assay retentate sample with centrifugal filter for A. 
salmonicida and Y. ruckeri 
 
 
 
 
  
24 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
A. salmon. + sample dilution 0.322 0.316 0.311 0.302 0.292 0.283 0.283 0.267 0.26 0.292 0.295 0.298 
A. salmon. + sample dilution 0.332 0.298 0.973 0.31 0.291 0.291 0.288 0.316 0.307 0.294 0.326 0.268 
A. salmon. + sample dilution 0.314 0.314 0.332 0.313 0.307 0.32 0.323 0.352 0.339 0.311 0.309 0.283 
Y. ruckeri + sample dilution 0.348 0.307 0.352 0.341 0.322 0.331 0.36 0.36 0.369 0.345 0.3 0.248 
Y. ruckeri + sample dilution 0.329 0.315 0.39 0.453 0.359 0.374 0.388 0.372 0.42 0.363 0.279 0.252 
Y. ruckeri + sample dilution 0.315 0.295 0.345 0.371 0.348 0.341 0.374 0.361 0.331 0.329 0.236 0.245 
A. salmonicida  
GROWTH CONTROL 0.271 0.27 0.289 0.305 0.306 0.298 0.278 0.268 0.324 0.3 0.289 0.242 
Y. ruckeri 
GROWTH CONTROL 0.512 0.294 0.321 0.331 0.308 0.364 0.371 0.334 0.331 0.3 0.26 0.289 
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Table A.22: Twenty-four-hour spectrophotometer reading of microtiter assay filtrate sample with centrifugal filter for S. 
agalactiae and S. iniae 
 
  
24 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
S. agalactiae + sample dilution 0.715 0.512 0.653 0.7 0.733 0.757 0.788 0.766 0.755 0.758 0.748 0.724 
S. agalactiae + sample dilution 0.633 0.505 0.649 0.7 0.719 0.775 0.746 0.77 0.747 0.726 0.716 0.71 
S. agalactiae + sample dilution 0.556 0.518 0.56 0.566 0.531 0.534 0.512 0.514 0.532 0.518 0.499 0.49 
S. iniae + sample dilution 0.564 0.493 0.534 0.637 0.756 0.871 0.806 0.732 0.781 0.721 0.745 0.737 
S. iniae + sample dilution 0.526 0.543 0.558 0.568 0.541 0.514 0.508 0.53 0.509 0.506 0.498 0.478 
S.iniae + sample dilution 0.556 0.518 0.593 0.555 0.56 0.555 0.51 0.553 0.46 0.495 0.509 0.472 
S. agalactiae  
GROWTH CONTROL 0.649 0.566 0.571 0.593 0.673 0.469 0.436 0.515 0.547 0.454 0.567 0.443 
S. iniae  
GROWTH CONTROL 0.566 0.543 0.665 0.701 0.738 0.721 0.713 0.749 0.728 0.734 0.726 0.73 
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Table A.23: Zero-hour spectrophotometer reading of microtiter assay filtrate sample with centrifugal filter for A. salmonicida 
and Y. ruckeri 
 
  
0 Hr 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
A. salmon. + sample dilution 0.067 0.064 0.067 0.063 0.063 0.063 0.064 0.063 0.063 0.063 0.066 0.063 
A. salmon. + sample dilution 0.066 0.067 0.065 0.063 0.064 0.064 0.063 0.063 0.063 0.064 0.063 0.064 
A. salmon. + sample dilution 0.065 0.064 0.064 0.063 0.063 0.064 0.063 0.063 0.063 0.063 0.063 0.065 
Y. ruckeri + sample dilution 0.071 0.067 0.074 0.065 0.065 0.065 0.066 0.066 0.065 0.065 0.066 0.064 
Y. ruckeri + sample dilution 0.069 0.067 0.067 0.066 0.066 0.068 0.068 0.067 0.067 0.065 0.065 0.068 
Y. ruckeri + sample dilution 0.07 0.066 0.066 0.066 0.065 0.066 0.067 0.066 0.065 0.065 0.065 0.066 
A. salmonicida  
GROWTH CONTROL 0.067 0.065 0.065 0.064 0.063 0.065 0.064 0.064 0.064 0.063 0.064 0.062 
Y. ruckeri 
GROWTH CONTROL 0.069 0.066 0.067 0.065 0.065 0.065 0.065 0.065 0.065 0.067 0.065 0.066 
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Table A.24: Twelve-hour spectrophotometer reading of microtiter assay filtrate sample with centrifugal filter for A. 
salmonicida and Y. ruckeri 
 
  
12 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
A. salmon. + sample dilution 0.348 0.29 0.325 0.274 0.327 0.293 0.298 0.285 0.287 0.284 0.264 0.288 
A. salmon. + sample dilution 0.293 0.263 0.279 0.263 0.289 0.283 0.269 0.281 0.261 0.252 0.236 0.264 
A. salmon. + sample dilution 0.282 0.247 0.26 0.248 0.286 0.286 0.287 0.288 0.286 0.276 0.283 0.279 
Y. ruckeri + sample dilution 0.348 0.339 0.373 0.294 0.318 0.33 0.299 0.283 0.272 0.291 0.302 0.314 
Y. ruckeri + sample dilution 0.337 0.304 0.329 0.294 0.322 0.329 0.264 0.307 0.305 0.331 0.3 0.329 
Y. ruckeri + sample dilution 0.342 0.318 0.282 0.273 0.298 0.301 0.272 0.28 0.329 0.313 0.315 0.337 
A. salmonicida  
GROWTH CONTROL 0.293 0.211 0.241 0.249 0.247 0.243 0.238 0.237 0.26 0.281 0.273 0.271 
Y. ruckeri 
GROWTH CONTROL 0.339 0.3 0.329 0.28 0.301 0.297 0.294 0.303 0.306 0.299 0.307 0.304 
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Table A.25: Twenty-four-hour spectrophotometer reading of microtiter assay filtrate sample with centrifugal filter for A. 
salmonicida and Y. ruckeri 
24 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
A. salmon. + sample dilution 0.322 0.3 0.3 0.264 0.275 0.269 0.28 0.27 0.275 0.287 0.263 0.279 
A. salmon. + sample dilution 0.278 0.276 0.312 0.267 0.288 0.289 0.289 0.308 0.292 0.277 0.298 0.295 
A. salmon. + sample dilution 0.336 0.273 0.33 0.27 0.295 0.311 0.304 0.314 0.302 0.305 0.292 0.322 
Y. ruckeri + sample dilution 0.316 0.302 0.377 0.322 0.331 0.353 0.37 0.366 0.363 0.331 0.35 0.26 
Y. ruckeri + sample dilution 0.31 0.336 0.378 0.435 0.396 0.388 0.37 0.389 0.423 0.347 0.348 0.281 
Y. ruckeri + sample dilution 0.313 0.31 0.33 0.352 0.364 0.374 0.379 0.368 0.346 0.35 0.301 0.299 
A. salmonicida  
GROWTH CONTROL 0.322 0.309 0.325 0.331 0.371 0.317 0.317 0.311 0.34 0.332 0.304 0.252 
Y. ruckeri 
GROWTH CONTROL 0.315 0.32 0.339 0.377 0.373 0.412 0.436 0.374 0.385 0.349 0.278 0.294 
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Table A.26: Zero-hour spectrophotometer reading of microtiter assay filtrate sample with centrifugal filter for S. agalactiae 
and S. iniae 
 
  
0 Hr 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
S. agalactiae + sample dilution 0.06 0.059 0.059 0.058 0.059 0.058 0.058 0.058 0.059 0.06 0.059 0.059 
S. agalactiae + sample dilution 0.061 0.061 0.06 0.058 0.059 0.059 0.058 0.059 0.059 0.059 0.053 0.059 
S. agalactiae + sample dilution 0.061 0.062 0.062 0.061 0.059 0.061 0.061 0.06 0.059 0.056 0.053 0.059 
S. iniae + sample dilution 0.061 0.059 0.059 0.059 0.058 0.058 0.058 0.058 0.058 0.058 0.058 0.059 
S. iniae + sample dilution 0.061 0.083 0.061 0.061 0.058 0.061 0.062 0.06 0.06 0.059 0.06 0.06 
S.iniae + sample dilution 0.068 0.063 0.062 0.061 0.057 0.062 0.061 0.061 0.06 0.059 0.06 0.061 
S. agalactiae  
GROWTH CONTROL 0.061 0.059 0.063 0.06 0.06 0.059 0.06 0.06 0.06 0.064 0.061 0.059 
S. iniae  
GROWTH CONTROL 0.063 0.059 0.059 0.059 0.059 0.059 0.059 0.059 0.059 0.058 0.06 0.059 
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Table A.27: Twelve-hour spectrophotometer reading of microtiter assay filtrate sample with centrifugal filter for S. agalactiae 
and S. iniae 
 
  
12 Hrs 1:1 1:2 1:4 1:8 1:16 1:32 1:64 1:128 1:256 1:512 1:1024 1:2048 
S. agalactiae + sample dilution 0.741 0.659 0.669 0.633 0.642 0.64 0.663 0.656 0.664 0.653 0.656 0.628 
S. agalactiae + sample dilution 0.745 0.686 0.674 0.655 0.645 0.687 0.653 0.682 0.672 0.65 0.648 0.628 
S. agalactiae + sample dilution 0.753 0.499 0.547 0.548 0.51 0.505 0.475 0.485 0.507 0.497 0.474 0.467 
S. iniae + sample dilution 0.542 0.609 0.583 0.652 0.639 0.707 0.609 0.616 0.657 0.61 0.651 0.646 
S. iniae + sample dilution 0.493 0.521 0.538 0.545 0.517 0.49 0.48 0.505 0.489 0.483 0.474 0.447 
S.iniae + sample dilution 0.512 0.499 0.581 0.541 0.538 0.527 0.476 0.509 0.419 0.439 0.462 0.432 
S. agalactiae  
GROWTH CONTROL 0.796 0.539 0.54 0.576 0.602 0.398 0.375 0.455 0.477 0.395 0.498 0.391 
S. iniae  
GROWTH CONTROL 0.514 0.654 0.655 0.688 0.679 0.653 0.663 0.67 0.655 0.657 0.64 0.637 
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APPENDIX B: Statistical Analysis  
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